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Abstract 
 
 
The aim of this quasi-experimental pilot study was to examine if neurofeedback is associated 
with a reduction in some of the common symptoms suffered by traumatized refugees who 
have been exposed to war and/or torture. Furthermore, an ambition was to develop and test 
methods for conducting research with this group. Twenty-one individuals were divided into 
either a treatment-group (n=12) or a non-equivalent control-group (n=9). No attrition 
occurred in the treatment-group, whereas 2 individuals dropped out of the control-group. The 
treatment consisted of 8-10 sessions of neurofeedback, over a time period of 10-15 weeks. 
Five instruments were used (the PTSD Checklist: Civilian Version, the Hopkins Symptom 
Checklist -25, the Symptom Checklist: Subscale Somatization and WHO-5 – Wellbeing 
Index and the Pittsburgh Sleep Quality Index) to measure difference in symptom severity. 
The main analysis of the data was conducted using mixed-design MANOVA and ANOVA. 
The results indicated a significant improvement seen over time for the treatment-group when 
compared to a non-equivalent control-group, on 4 of the 5 instruments. Neurofeedback 
appears to be a promising treatment for individuals with PTSD, but more research needs to be 
conducted in a controlled setting before any claims can be made concerning efficacy. This 
study was conducted in cooperation with the Red Cross Center for Victims of War and 
Torture in Malmö, Sweden. 
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Introduction and Theory 
 
He heard people screaming from all directions and when the guards 
took off his blindfold, he saw naked men hanging from the ceiling with their 
heads facing downward in the interrogation cells. The torturers shouted their 
questions and whipped the limp, hanging bodies with stripped electric cables 
that peeled away skin and bits of muscle. 
The blood ran on the floor. 
It was completely surreal, like Dantes Inferno. The people who were 
tortured didn’t scream like people anymore. Their voices had changed. They 
were another type of creature. They were bellowing animals. [... ] 
They tied Mohammad’s hands behind his back and hung him up from 
a hook in the ceiling. [... ] “It was hell, even after just a few minutes,” says 
Mohammad, “It felt like my arms were being ripped off. The guards began to 
hit me with electric cables and batons. [... ] 
The torture continued hour after hour. When Mohammad lost 
consciousness, the torturers let him down to the floor. When he awoke in his 
own blood, they began all over again. [... ] 
“I was completely naked and they gave me electric shocks on my penis 
and in my anus with a batong,” says Mohammad. “They pushed in coca-cola 
bottles too. I screamed and I bled. I became one with the scream. I was not a 
human anymore. I was an animal that was being tortured to death. I saw 
myself from a distance and registered what happened. ‘This is the end’, I 
thought. ‘Now they are going to kill me.’ But they didn’t, 
unfortunately.”(translated by the authors, Svensson, 2011, pp. 18-20) 
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In this account, given in an interview to journalist Gert Svensson (2011), Mohammad 
tells the story of how he and others were tortured in Iran. Mohammad was imprisoned eight 
different times, and the length of his stays ranged from three months to three years. The first 
time he was only 16-years old, and was taken for writing articles that were critical towards 
the dictatorial regime. During one period of 18 months, he sat in the notorious Evin Prison. 
He was isolated to a small room and never knew whether it was night or day. He slept on a 
cement floor with his face pressed close to the crack in the door. During other prison stays he 
was crammed into cells with ten to twenty other prisoners in rooms that were only meant for 
four people. They took turns sleeping on the floor and those who did not have room had to try 
to sleep standing. Mohammed also tells of some of the different methods of torture that he 
and others were often victim to, methods like ‘Palestinian hanging’, electrical shocks to the 
genitals, mock executions and being forced to watch and take part in the beatings and torture 
of friends and loved ones. Most traumatizing perhaps was the torture of the shame and guilt 
affiliated with all of these and having to carry that with them in life. 
Mohammed fled to Sweden in 1988 and has been going to psychotherapy at the Red 
Cross Center for Victims of War and Torture in Stockholm since 1992. He eats six different 
kinds of painkillers and sedatives each day and has personal attendants without whom he 
would not even be able to carry out daily tasks like dressing, cooking, using the toilet and 
showering. He has gone through seven operations on his hips and back and avoided needing a 
wheelchair through exercising regularly. Mohammed says he never sleeps at night, but tries 
to sleep a few hours in the early part of the day when the daylight alleviates his nightmares 
and the presence of his personal attendants can help him feel a little comfort. He initially fled 
to Sweden with his wife, but because of his horrific nightmares, she was never able to sleep, 
lost weight and became ill. Eventually, she left and did not want anything more to do with 
him. Now Mohammad has not seen her in fifteen years. “I am completely alone in life,” (p. 
16) Mohammad tells the journalist. Most of his days, he lays in bed in his apartment, behind 
closed curtains, in the company of his computer and two televisions that he has running all of 
the time. “That way I feel less abandoned,” (p. 16) he says (Svensson, 2011).  
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The Effects of Trauma  
The effects of trauma are comprehensive and long lasting, often permanent, as 
depicted above in Mohammad’s story.  People who have experienced torture or trauma have 
a much higher risk of suffering from long-term health problems such as depression, substance 
abuse, suicide and anxiety related syndromes such as phobias or panic disorders (Carlsson, 
2005). Yet the experience of trauma can cause very different reactions in different people 
(Svensson, 2011). The ailments that affect people who have experienced trauma or torture 
can be very complex. In some cases, they can even be hard to trace back to the original 
trauma that they come from, for example aches in different parts of the body, dizziness, 
insomnia or stomach and intestinal problems (Svensson, 2011). Many survivors of war 
trauma and torture suffer from chronic pain (Department of Migration, Swiss Red Cross, 
2005). Continuing to experience symptoms relating to trauma long after the traumatic 
experience occurred often qualifies for the diagnosis of posttraumatic stress disorder (PTSD) 
(Elzinga & Bremner, 2002). 
 
PTSD and Complexities in Diagnosis. The International Statistical Classification of 
Diseases and Related Health Problems – Tenth Revision (ICD-10) describes PTSD as a 
disorder arising as a delayed or protracted response to an exceptionally threatening or 
catastrophic stressful event or situation of either brief or long duration (World Health 
Organization [WHO], 1990). The source of the injury, when discussing experiences of 
trauma, is of significance (Lahad & Doron, 2010). For example, stressors deliberately 
inflicted by people such as war or acts of violence, are harder to cope with than accidents or 
natural disasters like earthquakes or tsunamis, probably because they destroy trust in fellow 
human beings. Studies show that while 60 percent of those who experience rape will develop 
symptoms of PTSD, only 3.5-4 percent of those directly exposed to a hurricane will develop 
such symptoms. Exposure to war and political unrest are stressors that have been found to 
increase the likelihood for PTSD (Salem & Flaskerud, 2011). It has also been shown that 
symptoms of PTSD and associated disorders can start to manifest themselves for years after 
the original trauma. They may even re-emerge as a person ages and intensify due to things 
like decreased functional capacity, social marginalization, or death of a loved one. Real life 
events can throw an individual back into a relapse episode (Foa, Keane, Friedman & Cohen, 
2009)   
Some typical features of PTSD are: 
- Disturbing nightmares and insomnia 
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- Flashbacks or experience of reliving the torture  
- Avoidance of things or situations that can trigger the traumatic memory 
- Hyperarousal and hypervigilance 
- Strong feelings of shame and guilt 
- Numbness and emotional blunting 
- Detachment from other people 
- Loss of ability to trust other people 
- Difficulty having hope or belief in the future 
(WHO, 1990) 
The DSM-IV-TR (American Psychiatric Association, 2000) provides a similar 
description and to fulfill the PTSD diagnosis the manual has a list of six criteria, A-F. Criteria 
A has two parts and includes: A1, the person has had a traumatic experience that involved 
actual or threatened death or serious injury, or a threat to the physical integrity of oneself or 
others, and Criteria A2, the individual experiences an emotional response involving intense 
fear, helplessness, or horror. Criteria B entail at least one kind of persistent re-experiencing or 
intrusive recollection. The five examples listed include distressing dreams, avoidance 
behavior, vivid imagery and flashbacks. In Criteria C, seven examples of symptoms of 
emotional numbing or emotional avoidance are described. In order to fulfill the criteria, at 
least one of the symptoms has to be present. For Criteria D, two out of five symptoms of 
hyperarousal should be present. Criteria E concerns the duration of symptoms and Criteria F 
includes distress or impaired functioning (American Psychiatric Association, 2000).  
There has been substantial criticism concerning the DSM-IV-TR criteria for PTSD 
and the limitations of the PTSD diagnosis (Teodorescu, 2012). Criteria A has been criticized 
for having insufficient specificity, both for having stressor criteria that are too broad, and 
criteria for emotional response that are too narrowly defined. Certain types of events, such as 
religious or political persecution, can be a threat to the psychological integrity of a person 
and can cause a traumatic reaction, but since they are not always life threatening, causing 
injury or a threat to physical integrity, these examples might not meet the A1 criteria 
(Teodorescu, 2012). According to Herman (1992, cited in Teodorescu, 2012) in regards to 
refugees, “the symptoms found among these patients are usually too complex, heterogeneous 
and sustained to fit this single label” (p. 278). Disorders of Extreme Stress Otherwise Not 
Specified, or DESNOS, often referred to as Complex PTSD, has been suggested as a term 
that might better accommodate the intricacy of the symptoms found in refugee populations 
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(Teodorescu, 2012). In DSM-IV-TR, DESNOS is not accepted as its own diagnosis and is 
found under the diagnosis of PTSD. The fact that DESNOS does not require the A2 criteria 
enables it to capture a large range of emotional reactions to potentially traumatic events 
(Teodorescu, 2012). 
 DSM-5 came out in 2013, providing some changes to the PTSD diagnosis. In the new 
manual, for example, Criterion A2 was removed completely (American Psychiatric 
Association, 2013), leaving only A1, which is relatively unchanged. In addition, PTSD was 
moved out of Anxiety disorders and into a newly established category called “Trauma and 
Stress-Related Disorders”. Under PTSD, there are now four symptom clusters instead of 
three, which now include ‘Emotional numbing,’ in addition to the pre-existing clusters ‘Re-
experiencing’ (referred to as ‘Intrusions’ in this present study), ‘Avoidance’ and 
‘Hyperarousal/Hypervigilance’ (American Psychiatric Association, 2013; American 
Psychiatric Association, 2000). Three new symptoms have also been added: ’persistent 
distorted blame of self or others about the traumatic event(s)’, ’persistent negative emotional 
state’, and ’reckless or self-destructive behavior’ (American Psychiatric Association, 2013).  
Because of the rigorous empirical standard for the newest version of the DSM, and the 
limitation of existing evidence to support these conditions, DESNOS (or Complex PTSD) 
was not added as its own diagnosis (Friedman, 2013). Yet according to Friedman (2013), 
DESNOS (Complex PTSD) is now better included in the PTSD diagnosis with the addition 
of new symptoms that are commonly associated with that condition. 
 There are still many controversies concerning the PTSD diagnosis, even in DSM-5 
(Welch, Klassen, Borisova & Clothier, 2013). One of these criticisms has to do with concern 
about the expansion of the concept of trauma over subsequent DSM revisions. Another 
criticism is whether there was enough support to justify moving PTSD out of Anxiety 
Disorders. A third controversy debates how a broad qualifying range of traumatic stressors 
could make it more possible for people to malinger when reporting symptoms in personal 
injury cases, and the opposite ethical consideration, that the DSM criteria should not be 
changed just to decrease the problem of malingering, and that a higher threshold for 
qualification might make some individuals who truly have been traumatized ineligible for a 
PTSD diagnosis (Welch, Klassen, Borisova & Clothier, 2013).  
 Because of the DSM-5s relative newness, these differences are not very relevant for 
diagnosis that have already been made for participants in this current study. Also, because of 
differences in methods and opinions on how to categorize the symptoms found in this group, 
9 
 
this study will refer more to the common symptoms and not the diagnosis per se, although the 
term PTSD may occasionally be used for purposes of simplicity. 
 
The Mind and Body. When under extreme conditions, normal coping strategies do 
not always work (Department of Migration, Swiss Red Cross, 2005). Feelings such as 
powerlessness, hopelessness and fear of death can lead to over-arousal, desperation, panic, 
mistrust and intense terror. The body’s normal stress reactions, which are meant to facilitate 
survival, can persist, causing extreme physical and psychological strain. This along with 
physical injuries from direct bodily harm of torture can cause lasting problems with muscular 
tension and damage to the body. 
Experiences of trauma also can actually change the individual on a neurobiological 
level (Elzinga & Bremner, 2002; Kitayama, 2005; Rohleder, Joksimovic, Wolf & 
Kirschbaum, 2004; Sherin & Nemeroff, 2011). For example, prolonged exposure to stressful 
events causes an elevated activation of the hypothalamic-pituitary-adrenal (HPA) axis, which 
strongly influences emotions and memory (Elzinga & Bremner, 2002). Research shows that 
heightened cortisol levels over sustained periods can actually cause volume reduction in the 
hippocampus, a structure in the brain that is essential to the processing of memories. One 
meta-study examined nine different studies with a total of 133 test subjects all diagnosed with 
chronic PTSD, 148 controls who were healthy and 53 controls who were traumatized 
(Kitayama, 2005). The study found significantly smaller size in hippocampal volume in both 
right and left hippocampi in the subjects with chronic PTSD compared to both the healthy 
controls and the traumatized controls.  
Although prolonged stress causes elevated levels of cortisol, studies show that PTSD 
is actually associated with lower levels of cortisol production (Rohleder, Joksimovic, Wolf & 
Kirschbaum, 2004; Roth, Ekblad & Ågren, 2006), occurring as an effect of the exceeding 
cortisol levels and subsequent dysregulation of the HPA axis, the body’s stress-regulating 
system (Rohleder, Joksimovic, Wolf & Kirschbaum, 2004; Sherin & Nemeroff, 2011).  
 
Relationships, Loss and Loss of Basic Human Needs. Not only are the victims left 
with permanent physical injuries and psychological scarring, but the remnants of their 
suffering takes its toll on relationships with people they love (Svensson, 2011). Many who 
have been tortured or experienced harsh physical trauma, for example, have a hard time with 
physical or emotional intimacy. It can be difficult to regain contact with their bodies after 
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having learned to shut off physical sensations because of their association with pain (Levine, 
2010).  Even children can and often are affected and the legacy of trauma is inherited 
(Svensson, 2011).  Mental illness, for example, is more common among children of 
traumatized parents and it is suggested that parents who experience Complex PTSD have a 
harder time relating to their child’s needs and creating a secure attachment. There are tens of 
thousands of children and youth living in Sweden who are growing up with parents who have 
experienced extreme forms of trauma. 
Because of a general focus on trauma and the effects of trauma, one other very 
important aspect of a refugee’s experience is often overlooked, the aspect of “loss”. 
Experiences of war and forced migration involve many types of losses, for example the loss 
of loved ones, of community, of work and money and material possessions (Arcel, 
Folnegović-Šmalc, Kozarić-Kovačić & Marušić, 1995). There are also psychological losses 
like the loss of status, belief in oneself, trust in others, future hopes, a belief in personal 
invulnerability and especially, the loss of power. For example, the refugee might not have the 
ability to solve his or her problems in the new country in the way that he or she thinks is best. 
Loss of any kind can have an immense effect on a person’s thoughts, feelings and behavior, 
and it can hurt at the very core of a person.  
One of the main losses that all refugees share is the loss of home and all that it 
represents (Papadopoulos, 2002). Home is one of the most fundamental notions of humanity 
and is a concept that has both physical and psychological meaning. It is a place where 
personal things are stored, such as pictures, certificates about identity, clothes and books 
(Arcel et al., 1995). It is also a structure that holds together the people who are most familiar, 
the family. It is a place where memories are formed and where identity is created, holding 
representations for powerful feelings such as those of comfort and safety (Arcel et al., 1995; 
Papadopoulos, 2002). Papadopoulos (2002) refers to Bowlby’s idea of a secure base and the 
human tendency to remain in a particular and familiar local, in the company of particular, 
familiar people. It is therefore not so surprising that people’s attachment to their home is 
usually so strong that they leave only when the threat to their lives is impending, often 
leaving much later than it is wise to (Arcel et al., 1995). 
According to the well-known humanistic theorist Abraham Maslov (Passer & Smith, 
2007), human needs are arranged in kind of hierarchy, which can be illustrated in the form of 
a pyramid. Needs that are concerned with physical and social survival are most imperative 
and make up the lower levels of the pyramid. These are needs that are basic to human 
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existence, such as food and drink, safety, along with belongingness and love. Higher up in the 
pyramid are esteem needs, cognitive needs, aesthetic needs, and at the top, self-actualization. 
In Maslov’s theory, higher-level needs can only be met when needs beneath them are already 
satisfied. This also means that if a lower-level need is no longer satisfied, a person will 
experience ‘need regression’ and be forced to focus on meeting that lower-level need again 
(Passer & Smith, 2007). 
 
Migration Related Stress 
In this study, the words ‘refugee’ or ‘migrant’ will be used interchangeably, as they 
are often used this way in the literature that has been reviewed in preparation for this study. 
Most of the people that are included in this study have been victims of torture, as in the 
example of Mohammed, and all of them have experienced trauma after being exposed to war 
and conflict, and have then migrated to Sweden. 
Research shows that the act of migration itself can contribute to and compound 
symptoms of PTSD and migration itself is considered a risk factor for mental illness (Loue, 
2009; Salem & Flaskerud, 2011). Loue (2009) describes three phases in the migration 
experience, each of which can have an impact on a person’s mental health. The first phase, 
‘premigration’, is when individuals still live in their home country but are preparing to move, 
and are affected by factors such as economic conditions, political conditions, social status and 
educational level. Phase number two is ‘peri-migration’, which means the actual process of 
migration. This phase includes things like travel conditions, exposure to or witnessing 
violence, the number and nature of events witnessed and lack of access to food and water. 
The final phase is ‘post-migration’, implying the arrival in the country of destination. Some 
important factors of this phase are the availability of people from the same background to 
provide support, how similar or dissimilar the host country is from the country of origin, the 
conditions and length of stay before settlement in the receiving country and the level of 
acceptance in the host country (Loue, 2009). 
Several studies have shown the strong influence of migration on mental health and 
many have specifically investigated how factors specifically related to post-migration can 
affect the mental health of migrants. One large community-based study (Bogic et al., 2012), 
where 854 former Yugoslavian refugees living in Germany, Italy and the UK were 
interviewed and compared, showed that there were significant differences in countries of 
resettlement and how the differences effected the mental health of the refugees. For example, 
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71.4% percent of the refugees living in Italy had employment, while only 23.1% of the 
resettled refugees in Germany had found employment, and results showed that 
unemployment accounted for the largest difference between countries in rates of mood 
disorders. Other findings showed that post-migration trauma exposure and stress, including 
the feeling of not being accepted in the host country, were positively associated with both 
mood and anxiety disorders. More than half of the refugees in the study still had temporary 
residency status, even though they had been residents of the host country for an average of 9 
years, and not having residency status was shown to be associated with higher rates of both 
mood and anxiety disorders. Evidence from the study further suggests that prolonged 
unstable residential status and living under a continuous threat of repatriation may contribute 
to the persistence of mental disorders in refugees. 
A number of Scandinavian studies have shown similar results. One study (Sundquist, 
Johansson, DeMarinis, Johansson & Sundquist, 2005) investigated 163 Bosnian women who 
had migrated as refugees after the start of the civil war in 1992 and resettled in the Swedish 
cities of Lund and Malmö. These women were compared with 392 Swedish born women 
living in the same two cities. The results showed that the Bosnian women had a much higher 
prevalence of PTSD, and of those, most of them showed symptoms of depression (94.1%), 
anxiety (97.1%) and psychological distress (97.1%). Even out of the Bosnian women who did 
not have PTSD, 51.2% had symptoms of depression, 52.3% had symptoms of anxiety and 
58.1% had symptoms of psychological distress. In the Swedish group, only 0.3% (one 
person) had PTSD and of the Swedish group, only 19.2% had symptoms of depression, 
12.7% had symptoms of anxiety, and 20.6% experienced psychological distress. Statistical 
calculations revealed that factors like economic difficulties, poor social network and not 
feeling secure were accountable for the symptoms found in the group of Bosnian women. 
Roth, Ekblad and Ågren (2006) did a longitudinal study on a sample of refugees who 
had fled to Sweden from Kosovo, where they were then able to follow-up after 1.5 years and 
compare results with a portion of the sample who chose to remain in Sweden and a portion 
who had chosen to repatriate to Kosovo. Results from this study showed that those who 
remained in Sweden and did not return to their homeland had a significantly higher rate of 
PTSD after 1.5 years, 85%, compared with 52% for those who had returned to Kosovo. The 
results also showed a significantly lower level of cortisol in the group that remained in 
Sweden which is an interesting find, since low levels of cortisol have been found to be linked 
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with PTSD, and a lower level in the group that stayed in Sweden further implies the level of 
their stress. 
Another study (Tinghög, 2010) compared the situations of 259 Iraqis and 250 
Iranians with 211 Finns living in Linköping, Sweden. The results showed that anxiety and 
depression (measured by HSCL-25) were much higher among the Iraqis and Iranians 
compared with the Finnish population.  Immigrant-specific factors like poor socio-cultural 
adaptation, non-immigrant specific experiences of traumatic nature such as high number of 
types of traumatic episode and non-immigrant-specific factors like poor economic security 
and poor social network, were found to be able to explain a major part of the markedly higher 
prevalence of mental ill health among the Iraqi and Iranian immigrant groups in comparison 
to the Finnish immigrant group.  
A Norwegian study (Teodorescu, Heir, Hauff, Wentzel-Larsen & Lien, 2012), using 
refugees from 21 different countries, assessed stressors like post-migration stress, 
unemployment, weak social network, weak social integration in the Norwegian society and 
weak social integration in the immigrant ethnic group from Norway. Results showed a strong 
positive association between weak social network and current PTSD, major depressive 
disorder (MDD), psychiatric morbidity and higher levels of psychiatric symptomology. 
Unemployment was associated with current PTSD diagnosis, psychiatric morbidity and 
higher levels of depressive symptomology. Weak social integration in the Norwegian society 
and weak social network were the post-migration variables that showed the most significant 
associations with poor mental health. 
Results from these studies imply that refugees often face significant post-war trauma 
during resettlement, including stressors like uncertainty about family members left behind, 
unemployment, economic difficulties and acculturative stress.  The evidence from these 
studies also points to the compounding effect of pre-migration trauma and post-migration 
variables on mental health. Many of the studies also indicate a relationship between 
depression and/or depressive symptoms and post-migration factors, such as social isolation or 
weak social network, unemployment and acculturation stress/social integration. Arcel et al. 
(1995) discusses the importance of a feeling of “empowerment” in the new/host country and 
how policies of, for example, temporary status and marginalization, will keep them 
disempowered for a long time. A policy of integration into the society, however would 
enlarge social functioning and increase psychological coping (Arcel et al., 1995). 
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Sweden and Migration 
A UNHCR report from June 19, 2013 (New UNHCR report, 2013) states that there 
were more than 45.2 million people globally in situations of displacement at the end of 2012. 
That is an increase from the 42.5 million they reported at the end of 2011 and does not 
include the rise in people forced from their homes in Syria during that current year. This 
means that there are now more refugees and displaced people worldwide than at any time 
since 1994. War is the main cause, and 55% of all of the refugees listed in the report come 
from Afghanistan, Somalia, Iraq, Syria and Sudan. In 2012, Iraqis were the third largest 
refugee group, with 746,700 people. In 2012, nearly 1.5 million people living in Sweden 
were born in other countries, which makes up about 15% of Sweden’s total population 
(Migration Sverige, 2014). In 2012, 98,822 refugees came to Sweden from Iraq alone 
(Sedghi, 2013). That same year, only 12,000 refugees in Sweden received asylum. Most 
requests for asylum are denied (Flyktingar i Sverige, 2013).  
Between 1950 and 1967, Sweden had a policy of allowing free immigration of labor 
force, which basically meant that anyone who wanted to settle in Sweden could do so without 
the state interfering (Westin, 2000). Sweden had no legislation guiding the integration of 
immigrants and people who immigrated were integrated into society just by being a part of 
the labor force. The 1990s marked a time of many changes to Swedish immigration policies. 
For example, harsher criteria were enforced with new ideas about how immigrants should be 
assimilated and how immigration should be limited. Since that time, immigrating to Sweden 
has been more difficult and the criteria to stay as a refugee are much more restrictive. Such 
restrictive policies, as previous theory has suggested, seem to have a negative impact on the 
mental health of refugees.  
Even gaining admittance to Sweden does not mean getting full access. Of the many 
societal issues of concern for refugees, one of the most distressing is perhaps discrimination. 
“Det blågula glashuset” (“The Blue -Yellow Glass House”) (Statens offentliga utredningar, 
2005), the resulting report from an investigation into structural discrimination in Sweden, 
revealed that discriminatory practices are present all throughout society. This includes the 
labor market, the housing market, the mass media, the political system, the legal system, the 
educational system and even welfare service areas, like the social services and the health care 
system. These examples show the unfair plight that is commonly a part of the refugee 
experience, and some of the many barriers to successful integration into the Swedish society.  
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Treating Victims of War and Trauma 
Treatment for trauma and trauma related disturbances has been discussed in health 
care literature for over 100 years, but research on efficacy of PTSD treatments began when 
PTSD was introduced into DSM-III in the 1980’s (Foa et al., 2009). This research has helped 
provide a better understanding and it is now known that early intervention after experiencing 
a traumatic event, leads to a better prognosis and can help prevent the development of 
chronic and more complex PTSD. Chronic or Complex PTSD is believed to be more difficult 
to treat. Because PTSD is twice as common among women as men, questions have arisen 
concerning gender difference and treatment, but the studies conducted to date have not been 
able to provide any conclusive insights into that aspect (Foa et al., 2009).  
The Posttraumatic Stress Disorder Treatment Guidelines Task force was founded by 
The Board of Directors of the International Society for Traumatic Stress Studies (ISTSS) to 
provide information to professionals about the most effective treatments for PTSD. After 
extensive review of clinical research and literature, the Effective treatments for PTSD: 
practical guidelines from the International Society for Traumatic Stress Studies (Foa et al., 
2009) was put together, and has since been widely referred to in research and literature 
relating to treatment for PTSD. What is interesting is that even after this extensive review of 
the field, no straightforward conclusions can be found to be drawn by the authors of the book 
concerning which treatments are best to recommend.  Because of methodological limitations  
implicated by among other ethical aspects when working with a PTSD population, conclusive 
controlled studies are scarce, and although other treatments such as group-therapy, 
psychodynamic therapy and creative therapies are common and frequently considered 
successful, they are often not considered ‘evidence-based’ because of the lack of research 
(Foa et al., 2009).  
For the purpose of providing a background for treatment in this pilot-study, the focus 
here will be on the two treatment methods that have been backed by the most empirical 
evidence, CBT and EMDR, which are further supported in reviews by Ponniah and Hollon 
(2009) and Palic and Elklit (2010). Still, the authors of this study are aware that these 
methods are more researched partly due to the fact that it is often more feasible to conduct 
research with these particular methods in comparison to other methods, as is also mentioned 
by Foa et al. (2009), Ponniah and Hollon (2009) and Palic and Elklit (2010).  
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Cognitive Behavioral Therapy (CBT). CBT for PTSD involves several different 
techniques, thus CBT in this context is a broad area (Foa et al., 2009). Harvey, Bryant and 
Tarrier (2003) in a literary review, found that CBT treatment for PTSD most commonly 
contains psychoeducation about common symptoms, exposure, cognitive restructuring, and 
anxiety management. The treatment duration varies but is typically 9–12 sessions, each 
lasting between 60 and 90 minutes (Harvey, Bryant & Tarrier, 2003). The Posttraumatic 
Stress Disorder Treatment Guidelines Task force, on the other hand, recommends 8-15, 60-
120 minutes (Foa et al., 2009). Harvey, Bryant and Tarrier (2003) also found a strong 
indication for the efficacy of CBT for PTSD across a range of trauma groups, where exposure 
therapy was concluded to be the most efficient intervention.  
Since CBT can consist of a combination of many different methods, one cannot say 
that there is one specific working mechanism for CBT-treatment for PTSD (Foa et al., 2009). 
Exposure therapy, sometimes also often referred to as prolonged exposure, requires the 
patient to confront a frightening, but safe, stimulus until anxiety is reduced. Exposure for 
traumatic memories is often referred to as imaginal exposure. Repeated imaginal reliving is 
believed to promote extinction of conditioned fear reaction, making the working mechanism 
of this technique conditioning. It is noteworthy that exposure therapy is not commonly used 
separately, but rather in combination with other CBT technique such as relaxation training 
and psychoeducation (Foa et al., 2009). Even though exposure therapy has proven effective 
in research settings, it is underutilized in clinical settings, assumingly partly due to patient’s 
reluctance to the exposure process (Jaeger, Echiverri, Zoellner, Post, & Feeny, 2010). 
 
Eye Movement Desensitization and Reprocessing (EMDR). One method 
commonly associated with treatment of PTSD was first introduced by Shapiro in 1989 as 
EMD and later progressed into what is now widely known as Eye Movement Desensitization 
and Reprocessing, or EMDR (Schubert & Lee, 2009). Shapiro also developed the adaptive 
processing model (AIP) to explain the effects seen by EMDR. The model posits that our 
combined experiences are stored in memory networks (Oren & Solomon, 2012), and that this 
is the foundation for either mental health or pathology (Oren & Solomon, 2012; Shapiro, 
2012). If we have a new experience that is properly processed by the brain’s information 
processing system, it is integrated into an adaptive memory network. When we have an 
experience that is disturbing or distressing, whether trauma or negative everyday events, this 
can overwhelm the information processing system, preventing the experience from being 
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integrated, and thus resulting in an unprocessed or faultily stored memory (Oren & Solomon, 
2012). Shapiro claims (2001, referred in Ho & Lee, 2012) that during EMDR treatment, new 
associations are formed between the unprocessed or faultily stored memory and the adaptive 
memory network, allowing consolidation to occur. Also, according to Shapiro, EMDR 
alleviates distress by facilitating access to the traumatic memory network and allowing this 
consolidation to occur by forging associations between the traumatic memory and more 
adaptive memories or information. Treatment is continued until the memory network is fully 
resolved and restored (Shapiro 2001, in Ho & Lee 2001). 
There has been some debate about what the working mechanism of EMDR actually 
is. One possible explanation for the treatment’s efficacy is that adaptive reconsolidation of 
the memory becomes possible because the lowering of psychophysiological arousal and 
increase in parasympathetic activation enables the dysfunctionally stored memories to be 
linked to adaptive information from other memory networks. Studies have shown a 
correlation between eye movement and desensitization (Schubert & Lee, 2009) and that 
EMDR causes an increase in parasympathetic activation and a decrease in 
psychophysiological arousal (Sack, Hofmann, Wizelman & Lempa, 2008). Yet some claim 
that the working mechanism in EMDR is actually the same as in CBT, for example 
conditioning (extinction), and that EMDR is a version of CBT and not a unique method of 
therapy (Ho & Lee, 2012).  
Shapiro (2012) says that the procedure used in EMDR violates the standard exposure 
theory. In EMDR disturbing memories are only given brief attention and an association 
process is included, whereas in prolonged exposure the patient is required to focus on the 
traumatic memories for a long period of time for habituation to be able to occur. One of the 
benefits with EMDR is that patients are not encouraged to focus on the disturbing memories 
for a long period of time in order to achieve habituation (Schubert & Lee, 2009).  
 
Neurofeedback 
Neurofeedback training is brainwave biofeedback, which can be performed using 
several different brainwave measurements, among the most common are 
electroencephalography (EEG), functional magnetic resonance imaging (fMRI) and low-
resolution electromagnetic tomography (LORETA). In this study the term “neurofeedback” 
will refer to EEG neurofeedback if not otherwise specified. Biofeedback is a broader term 
than neurofeedback and means that an individual is shown a real-time reflection of a certain 
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physiological activity, not exclusive to brain activity. The physiological activity given 
feedback on is chosen depending on the targeted symptoms. By getting feedback on their 
biological activity the individual has the opportunity to influence and increase their control 
over the activity. Other forms of biofeedback have been proven effective for headaches, 
hypertension and incontinence among other things (Hammond, 2006).  
Every person at any given time has different brainwaves at different frequencies 
present in their brain, and depending on their amount and the areas in which they are located, 
they generate different levels of awareness (Hammond, 2006; 2011). The waves can be 
measured in cycles per second or hertz (Hz), and beta, alpha, theta and delta are some of the 
classic EEG bands. Beta waves are above 13 Hz, which are smaller in amplitude and faster 
and are associated with intellectual processing and a state of alertness. Alpha waves are 8-12 
Hz, meaning they are larger  in amplitude and slower, and these are associated with a state of 
relaxation. Theta waves are very slow and even larger in amplitude at 4-8 Hz. They relate to a 
daydream-like, spacey state of mind, reflecting mental inefficiency. Delta waves are the 
slowest with the highest amplitude at 0.5-3.5 Hz. These represent the state of sleep. 
Furthermore sensorimotor rhythm (SMR) is not a specific EEG band but represents the 
frequencies 12-15 Hz and is associated with relaxed attentiveness (Hammond, 2011).  
Neurofeedback training is performed by placing electrodes on a person’s scalp 
(Hammond, 2011). The electrodes then record the electrical currents from the brain without 
any electricity being put into the brain. Then the brainwave activity is reflected on a monitor 
or computer screen, however the fashion in which this is done can differ (Hammond, 2011). 
Normally, a person does not have the opportunity to affect or regulate his or her own 
brainwaves (Hammond, 2006). By letting a person, in real-time, monitor a reflection of the 
patterns of electrical activity in the brain, neurofeedback makes it possible to retrain and 
recondition brainwaves.  
The mechanism of action is believed, by some, to be operant conditioning 
(Hammond, 2011). Dias and Van Deusen (2011) say that “neurofeedback is built upon the 
self learned practice of conscious generation of more healthy organic patterns” and, like 
Hammond, they also say “the technique represents a form of operant conditioning”. Some 
claim that the mechanism of action is not understood and thus is still unknown (Niv, 2013). 
Whilst others perceive neurofeedback as being partly defined by the operant conditioning that 
they believe is taking place, Sherlin et al. (2011) describes neurofeedback as “a learning 
process utilizing operant learning mechanisms of brain activity” (p. 301. Sherlin et al. 2011) 
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The length of a neurofeedback treatment differs over conditions and depending on the 
severity to which the symptoms are experienced (Hammond, 2011). Insomnia and anxiety 
problems might require 15-20 sessions, whereas ADHD might require 30-50 sessions. In 
many cases the first improvements can be seen after five to ten sessions. Furthermore, 
different frequencies are explained as easier or more difficult to selectively train and 
therefore require different treatment lengths (Niv, 2013). For example, in neurofeedback 
training with the SMR band, a change can be expected after 8 sessions, whereas with the 
theta band it cannot.  
A said benefit of neurofeedback is that it offers a way to modify brain activity without 
introducing anything else into the brain (Niv, 2013). Other techniques make use of electric or 
magnetic activity, or pharmacological compounds, which can result in side-effects or an 
outside dependency in order to sustain the improved functioning (Niv, 2013). 
Neurofeedback is still a new method and is not commonly used. In 2010, a Web-
based survey was distributed among the prescribers of the psychotherapy magazine The 
Psychotherapy Networker, that inquired about which element practicing psychotherapists 
included in their clinical work (Cook, Biyanova, Elhai, Schnurr & Coyne, 2010). Among the 
2,200 psychotherapists working in North America who responded, less than one percent 
reported using either neurofeedback or biofeedback in their work (while two percent reported 
using EMDR). 
 
Previous Research Using Neurofeedback. Neurofeedback has been applied on a 
range of clinical conditions. It developed from the field of biofeedback, which had already 
shown promising results in areas such as treatment for epilepsy, migraines and pain (Niv, 
2013). Among the earliest studied areas for neurofeedback were epilepsy and relaxation 
(Hammond, 2011). Furthermore, neurofeedback has also been researched and used in such 
areas as athletic performance (Perry, Shaw & Zaichowsky, 2011), autism spectrum disorders, 
learning disabilities and creativity (Hammond, 2011; Niv, 2013).  
One of the most researched areas for neurofeedback is the effect it has on ADHD. In 
a meta-analysis, Arns, De Ridder, Breteler, Coenen & Strehl (2009) came to the conclusion 
that neurofeedback treatment of ADD/ADHD “meets criteria for being classified as an 
efficacious and specific treatment—the highest level of scientific validation.” One study of 
102 children diagnosed with ADHD (ages 8-12) compared combined neurofeedback 
(theta/beta training and slow cortical potential) training and attention skills training. It 
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concluded that neurofeedback training produced a greater reduction in ADHD symptoms than 
attention skills training (Coghill, 2010).  
Some areas of research that are particularly relevant to this present study are the 
effects of neurofeedback on areas like headaches, sleep, anxiety, depression and emotional 
regulation.  In a review about neurofeedback, Hammond (2011) reports good findings for the 
treatment of migraines with neurofeedback. In one study, a follow up one year after 
completed treatment showed complete cessation in migraines in 54% of the test-group and 
0% in the control-group (Hammond, 2011).   
When it comes to depression, neurofeedback treatment is an up-and-coming area, 
where many methods of neurofeedback are being studied. Choi et al. (2011) using a  10-
session neurofeedback treatment, that aimed at regulating alpha activity in the mid-frontal 
areas, found that depressive symptoms were alleviated and performance in executive 
functioning was improved in a experimental-group, in comparison with a placebo-group. 
Right frontal alpha asymmetry has been linked to internalizing symptoms associated with 
both depression and anxiety (Niv, 2013). Furthermore, at a two-year follow-up, also using an 
alpha asymmetry neurofeedback protocol, Saxby and Peniston (1995, referred in Dias and 
Van Deusen, 2011) found results that indicated a 92 % effectiveness for depression in 
comorbidity with alcoholism. Dias and Van Deusen (2011) found a 43 % reduction in 
reported mental suffering in a study designed to test a new protocol for depression, 
integrating alpha asymmetry and theta/beta ratio within left prefrontal cortex.  This was 
measured on a seven item self-report scale that included: anxiety, irritation, negative 
thoughts, obsessive thoughts, agitation, frequent crying and difficulties falling asleep. 
Sustained effect was reported one month after treatment cessation (Dias & Van Deusen, 
2011).  
Another study found that clinical symptoms for depression, measured by the 
Hamilton Rating Scale for Depression (HDRS), was significantly improved in the test group 
in comparison to a control-group. This improvement was observed after a four-session fMRI 
neurofeedback training that targeted regulation in brain areas such as the insula and 
ventrolateral prefrontal cortex. Different levels of activity in these areas can be said to be 
associated with either positive or negative emotions (Linden et al., 2012).  
Using a LORETA neurofeedback treatment which targeted a high-beta activity in 
cortico-limbic/paralimbic regions, Paquette, Beauregard and Beaulieu-Prévost (2009) found 
that the percentage of reduction found for the participants was significantly correlated with 
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the percentage of change in depressive symptoms. In addition, Niv (2013) makes a note in 
her review of the clinical effects of neurofeedback, that promising results have been found 
using infra-low neurofeedback (description provided below) in treatment of depression. 
In regards to sleep, neurofeedback has been found to be linked to sleep enhancement. 
Cortoos, De Valck, Arns, Breteler & Cluydts, (2010) found, using a SMR upregulation 
protocol, a significant increase in total sleep time in a group that suffered from insomnia, in 
comparison with a baseline-group. Similar findings have also been found in another study. 
After a neurofeedback treatment of ten sessions, a reduction in sleep latency and an increase 
in sleep spindles could be observed, as well as an improvement in declarative memory, which 
was presumed to be linked to the occurrence of memory consolidation during sleep 
(Hoedlmoser et al., 2008). 
  
Biofeedback, Neurofeedback and PTSD. So far, very little research has been done 
on the effects neurofeedback and other kinds of biofeedback have on symptoms of PTSD, 
and those studies that have been done are mostly on war veterans returning to their own 
country.  
Previous attempts have been made to test if biofeedback is useful in helping with 
symptoms of PTSD.  One particular study tried to use biofeedback for pain management in 
traumatized refugees (Muller, 2009). The procedure consisted of 10 sessions and included 
electromyographic (EMG) biofeedback, which measured psychophysiological reactivity, 
along with other interventions and strategies for physiological relaxation. The rational for the 
study was that biofeedback, since it provides immediate physiological feedback, is largely 
experience-based, meaning that language differences would not be as much of an obstacle in 
this kind of treatment as it might be for psychotherapy. Results from the study showed little 
effect on the treatment of pain, but found medium to large effects for PTSD symptoms, 
depression and anxiety. There were also significant effects on cognitive and behavioral 
coping with pain (Muller, 2009).  
Peniston (1986, referred in Graap & Freides, 1998), first used EMG biofeedback 
(applied within a desensitization framework) to find out if it could aid in decreasing PTSD 
symptoms. Levels of stress were measured as the degree of muscle tension in the forehead, 
recorded by EMG electrodes. The hypothesis was that via biofeedback on muscle tension a 
systematic desensitization would occur. The experiment- and control-groups were randomly 
assigned from a group (n=16) of participants recruited through the Fort Lyon VA Medical 
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center (VA), where American veterans had sought treatment for PTSD symptoms.  The result 
of the study showed a decrease in muscle tension in the experiment-group at the end of 
treatment. In a comparison between the experiment-group and the control-group at a 24-
month follow-up, results showed a significant decrease in anxiety-producing nightmares and 
flashbacks. 
Later, in 1991, Peniston and Kulkosky (referred in Graap & Freides, 1998) wanted to 
examine if a decrease in PTSD symptoms could be obtained using an alpha-theta 
neurofeedback protocol, which was combined with temperature biofeedback. As in 
Peniston’s previous study, participants (n=29) were recruited from the VA and then randomly 
assigned to an experiment or control-group. At the end of treatment, significant changes 
towards a normalization in Minnesota Multiphasic Personality Inventory (MMPI) could be 
seen in the experiment-group, along with a decrease in psychotropic medication and a 
decrease in anxiety-provoking dreams or nightmares (Graap & Freides, 1998). Regarding the 
MMPI, both groups showed a normalization in the schizophrenia subscale, but the 
experimental-group also showed a reduction in the following subscales: depression, 
hypochondria, hysteria, psychopathic deviation, paranoia, psychotheina, hypomania, 
introversion and the PTSD subscale (Niv, 2013). A 30-month follow-up showed that the 
experimental-group still experienced fewer anxiety-provoking dreams and nightmares than 
the control-group (Graap & Freides, 1998). In the control-group, all participants had relapsed, 
whereas only one in the experimental-group had (Niv, 2013). 
In studies on veterans, promising results have been found for PTSD using infra-low 
frequency training, which is a form of neurofeedback that targets EEG frequencies ranging 
from 0.1 to as low as 0.01 Hz  (Niv, 2013; Othmer, 2012). Othmer (2012) has, through pilot-
studies conducted on military bases and via a network of neurofeedback clinicians, been able 
to find some very encouraging indications for the effectiveness of infra-low neurofeedback 
for PTSD. For example, he found that 25 % of the treated patients had, after less than ten 
sessions, experienced considerable relief for all of their PTSD symptoms. For 50 % of the 
treated patients, the response was more moderate.  
Furthermore, promising findings have been found using a combination of alpha/theta 
training and infra-low neurofeedback training on veterans with combat-related symptoms, in 
a non-controlled study conducted by the U.S. Navy (Niv, 2013). The treatment consisted of 
approximately 20 sessions of neurofeedback.  Fourty-five concurrent symptoms were 
tracked, such as flashbacks, nightmares, migraines, irritability, lack of motivation, poor sleep 
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quality and depression. Niv (2013) reported large effect-sizes for specific symptoms, such as 
0.84 for depression, 0.8 for sleep-related symptoms, 0.96 motivation improvement and 0.5 
for migraines.  
  As of this present study, no studies have been found showing the effect of 
neurofeedback on traumatized refugees who have been forced to relocate and assimilate to a 
new culture, which might make this study the first of its kind.   
 
Study Aims 
 
The literature and theories presented above show how the physical and emotional 
effects of trauma can be severe and are often long-lasting or even permanent. The human 
body is meant to react to stress in a certain way to ensure survival, but prolonged, sustained 
stress can actually cause neurobiological dysfunctions. There is an abundance of evidence 
revealing that even the process of forced migration can be challenging and can possibly 
amplify the effects of trauma. In addition, there is an aspect of how humans-beings relate to 
loss, particularly the loss of identity and sense of home and security, and how human beings 
have essential human needs that need to be met. A number of methods are currently being 
used to treat traumatized individuals and people with PTSD, but only a few, such as CBT and 
EMDR have substantial, rigorous empirical support. Neurofeedback is a treatment method 
where brainwave activity is measured and information about that activity is given back to the 
subject as feedback so that brain activation can be retrained and regulated. This treatment 
form has shown promising results in improving concentration, performance, and emotional 
regulation, among other areas, and it has been shown to help in problems like stress, 
depression, ADHD, migraines and sleep disturbances.  
No study however, can be found where neurofeedback treatment is used for 
traumatized refugees, but the little formal research that has been done in adjacent areas looks 
promising, and demonstrates the importance of further investigating this treatment method. 
Additionally, findings from previous research and knowledge of how trauma affects people, 
biologically and psychologically, give reason to believe that neurofeedback could possibly 
have a positive effect on this group.  
- The main purpose of this pilot study was to examine if neurofeedback treatment 
could be found to be associated with a significant reduction of the common 
symptoms suffered by traumatized refugees who have been exposed to war and/or 
torture.  
24 
 
- An additional goal was to obtain information on how to perform further research 
concerning this group and how to improve treatment methods to better help these 
patients.  
 
The purpose of the second goal was to shed more light on how to best utilize data that 
is already being collected by the Red Cross Center, examine what research methods are 
useful to use and become more aware of what questions could need further investigation in 
future studies. An example of information that could be useful was whether this patient group 
has tolerance for (meaning that they can actually follow through with) this type of treatment. 
Yet, since this particular goal had to do with acquiring information to fill deficits in current 
knowledge, it was difficult to give specific examples about what knowledge was sought after.   
 
Method 
 
This pilot study was performed by two masters level students at Lund University, in 
conjunction with the Red Cross Center for Victims of War and Torture in Malmö, Sweden.  
The Red Cross Center, where the study took place, has been established in the city of Malmö, 
Sweden for more than 30 years. Their purpose is to treat, rehabilitate and reduce the suffering 
of refugees who have been victim to the traumas of war and torture. In addition, they work in 
the community to educate and influence changes that can improve the situation for this 
particular group. The center’s employees consist of 1 physician, 2 physical therapists, 4 
psychologists, 1 social worker, 1 occupational therapist, 2 secretaries, and 1 managing 
director.  79% of the patients need translators each time they come in to the center for 
treatment, so the center regularly employs translators. In addition, they have practitioners 
who can speak a variety of languages.  Some of the main treatment forms that are used at the 
center are psychodynamic psychotherapy, cognitive behavioral therapy, group therapy and 
physical therapy. In the year 2012, the center treated 492 patients. All of the patients are 
refugees who have been victim to trauma and war, and over 50% of the patients have 
experienced torture (Röda Korset, 2013).   
In the beginning of 2013, two practitioners at the center who had become certified 
Neurofeedback Therapists after attending clinical training through EEG Info (approved by 
the American Psychological Association) started providing the treatment for a few of their 
patients. From this, the idea was formed to perform a study that would investigate whether 
25 
 
results from this new treatment could be seen and evaluated. In this study, all treatment 
sessions were carried out by these two certified neurofeedback practitioners, both of which 
have been working at the Red Cross Center for several years and have much experience 
working with this patient group. 
 
Procedure 
In the autumn of 2013, a study design was agreed upon in collaboration with the Red 
Cross Center. A sample was then chosen from patients on a waiting list who were referred to 
the Red Cross Center from another governmentally initiated center providing services for this 
patient group. For the purposes of confidentiality, the authors of this study have renamed this 
separate establishment “the Migration Depot” for reference use in this study. A sample was 
chosen specifically from the Migration Depot because this group was known to be more 
homogenous than the patients on the Red Cross Center’s main waiting list, and would 
therefore be better as the basis for a study. For example, most of these patients were Arabic-
speaking and had come to Sweden as refugees within recent years. Another advantage of 
doing a study with individuals from this center was that all individuals participating in the 
study would be able to receive consistent, simultaneous support outside of the study and the 
Red Cross Center (for example, help with immigration issues, employment, studies, etc.).  
Exclusion criteria for the study were non-Arabic speaking individuals, people 
currently experiencing severe stress on account of current or very recent traumatic 
experiences (recent death of a loved one), re-referred patients, or that they had already been 
offered other treatment (not at the Red Cross) while on the waiting list. Another exclusion 
criteria had to do with whether an individual would have trouble taking part in informational 
meetings about the study in a group setting. This information was deduced by the treatment 
providers at the Red Cross Center after examining information on the patient referrals.  
At the time of recruitment for this study, there were exactly 34 individuals from the 
Migration Depot on the waiting list to receive treatment from the Red Cross Center. Of these 
34 individuals, only 3 were females, possible because a women’s group had recently been 
formed at the Red Cross Center, which had taken in some women who had previously been 
on the list. Otherwise, statistics from the Red Cross Center show that women usually make up 
about one-third of their patient population.  Of these three women that were on the waiting 
list, only two met the exclusion criteria of speaking Arabic. After consideration from the Red 
Cross treatment providers in regards to the personal situations and trauma histories of the two 
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remaining women, it was deemed better not to place them in groups where they might end up 
being alone as women (after attrition or dividing the group into two). Therefore, the two 
women were also removed from consideration for the study. After applying all exclusion 
criteria, the sample was reduced to 24 male individuals (n=24).  
The initial idea was to try to create a randomized controlled study to best investigate 
this new treatment form and its effects on this patient group. However, in forming this study 
in conjunction with the Red Cross Center, in was deemed that it would not be ethical to 
allocate the patients randomly to different groups, when some of them had been on the 
waiting list for over a year and others only a few weeks or months. Because of the small size 
of the Red Cross center and natural limitations of time and resources, there is always a 
waiting list and openings are generally given to those who have waited longest. For this 
study, there were only two professionals trained in providing neurofeedback treatment, and 
they felt that twelve was the approximate limit of neurofeedback patients they could take in at 
one time while still meeting other patients and fulfilling their other duties at the Red Cross 
Center.  
It was decided that the best solution would be to split the sample of 24 into two 
groups, where the patients who had been on the waiting list longest were offered placement 
in the treatment-group and those who were further down on the waiting list were asked if 
they would like to participate by being a part of a second group that would be used as a non-
equivalent control-group. Those allocated to the non-equivalent control-group would receive 
the same treatment opportunity as soon as the study was completed.  
Fifteen individuals from the sample (n=24) were invited to take part in three 
introductory meetings. Eleven individuals came to the first meeting, October 14, 2013, at 
which information was given about the Red Cross Center and its employees. One person 
showed interest but could not make it to the first meeting. Instead he received information 
from the first meeting later that same week.  Another person came for the first time on the 
second meeting and was also offered information from the first meeting.  One person who 
was in the original group present at the first meeting did not show up to the second meeting.  
At the second meeting on October 21, 2013, information was given about PTSD and 
its symptoms. Psychometric measurements were also performed (more information about this 
will be provided in the section on test instruments). At the third meeting on October 28, 2013, 
information was given about neurofeedback and about the proposed pilot study. Individuals 
were offered the opportunity to participate in the study, but were assured treatment even if 
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they chose not to participate. From the original group of 15 individuals, 12 people 
participated in information about the study and gave informed written consent, wishing to 
participate in the pilot study. The three remaining individuals were asked if they would like 
to be a part of the non-equivalent control-group and all three consented. 
The non-equivalent control group was formed by first inviting the remaining 9 
individuals (from the original sample of 24) to another meeting. The 8 individuals that came 
to the meeting were given information about the study and asked if they wanted to 
participate, after which 6 showed interest and consented to participating in the control group.  
As previously explained, 3 more individuals who had declined their initial offer of placement 
in the treatment group were added to this group. This made a total of 9 individuals for the 
non-equivalent control group (n=9). 
In the two weeks after the initial three meetings, each participant in the treatment-
group was called in for an individual consultation to find out more about their personal 
trauma histories and their current situations. Questions were asked, for example, about 
medication they might be using, other treatments they might be participating in 
simultaneously, whether they have thoughts about suicide, how well they slept and other 
general questions about various factors that could be relevant during the neurofeedback 
treatment. For most of the twelve individuals in the treatment-group, neurofeedback training 
was begun within a week or two of their individual consultation. Three individual, because of 
conflicts in their personal situations, were not able to start right away and did not initiate 
neurofeedback treatment until January of 2014. Because they were not able to start for more 
than two months after the other participants started their treatment, these three individuals 
were retested with the psychometric measurements once again, just before beginning 
treatment. This provided the study with an unexpected opportunity to also compare the 
second pre-treatment measurements of these three individuals with initial psychometric 
results, providing an additional baseline measurement that could be interesting to examine in 
this study. 
Neurofeedback treatment was to be given to the treatment-group participants in a total 
of 10 sessions, over a span of approximately 10-15 weeks.  Psychometric tests, or pre-
treatment measurements, were performed about three weeks before the first treatment 
occasion, and post-treatment measurements were expected to be performed approximately 
one week after the final neurofeedback session. If the participants needed any other support, 
such as medication or therapy during the months of treatment, that was allowed even if that 
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would mean possible confounders in the findings of the pilot study. It was deemed more 
important to put the critical needs of the patients before a more rigid study design.  
Further documentation was collected by checking in with each participant at the 
beginning of every neurofeedback session. Participants gave details about relevant 
happenings in their personal lives that could have an influence on treatment. They were also 
asked to take a few minutes at the beginning of each neurofeedback session to fill out a 
symptom-tracking form (see Appendix 1) allowing them to describe their experience of their 
symptoms in the time since the last neurofeedback session. The point of the symptom-
tracking form was to help the practitioners and researchers get an idea of what was happening 
in the participant’s situations during the span of the study. It also provided a way of keeping 
an eye on the severity of the symptoms so that practitioners could be aware of sudden 
changes that might have signaled an emergency, such as a patient who needed to be taken out 
of the study and referred other help.  
After the conclusion of the last neurofeedback session and the post-measurements, the 
practitioners met again with each of the participants for a follow-up meeting to plan for their 
continued needs. Those who wished to continue neurofeedback would be given that 
opportunity, while others would if needed be remitted to psychotherapy, physical therapy, or 
other forms of treatment. 
 
Instruments 
All instruments for measurement used in this study are self-report questionnaires. 
Four of these tests, the PTSD Checklist, Civilian Version (PCL-C), the Hopkins Symptom 
Checklist-25 (HSCL-25), the Symptom Checklist (SCL-90), Subscale Somatization and the 
WHO-5 – Wellbeing Index (WHO-5), are well known as reliable instruments and widely 
used.  In addition, these four tests are routinely used by the Red Cross Center for Victims of 
War and Torture to assess the needs of incoming patients, which adds an additional benefit to 
the center and this pilot study, since using the center’s preexisting psychometric routines 
allows this study to meld into the working practices already in place at the center and can 
allow for easier implementation of continued treatment research at the center. The only 
additional test introduced for the purpose of this study was the Pittsburg Sleep Quality Index 
(PSQI), because experience at the Red Cross Center for Victims of War and Torture shows 
that sleep-related symptoms in this patient group are difficult to treat successfully, and any 
possible improvement in this area linked to neurofeedback would be a valuable finding.  
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All of the used measurement instruments are scored non-verbally, with the exception 
of PSQI, where a description of additional problems can be added. The additional 
information, if given, was translated for the study by the translators who are regularly 
employed by the Red Cross Center. Arabic versions were used for all of the questionnaires. 
The test instruments for pre and post-measurement in this pilot-study include:  
 
PTSD Checklist, Civilian Version. The PCL-C is a self-report questionnaire for 
PTSD symptoms (Foa et al, 2009). The respondents are asked to mark on a scale from “1” 
(not at all) to “5” (extremely) to which degree that they have been troubled by a certain 
symptom during the last month. The PCL-C is designed to correspond to the criteria set for 
PTSD by the DSM-IV-TR, seventeen items for the seventeen symptoms described in the 
DSM-IV-TR. It has three subscales, one for each of the symptoms clusters in the DSM-IV-
TR: intrusion, avoidance and hyperarousal. These subscales can be added together for a total 
score of between 17 and 85, or a score can be calculated for each subscale, with a possible 
score of 5-25 for intrusion, 7-35 for avoidance, and 5-25 for hyperarousal. 
 This instrument has been extensively used and assessed and is known for having 
exceptional psychometric properties across a diversity of trauma populations. The PCL is 
available in three different versions. The civilian version refers to trauma related events in a 
more general fashion, whereas the other versions are more specific.  The internal consistency 
coefficient (Cronbach's alpha) for the total scale is α = 0.939 (Foa et al, 2009). In addition, 
the PCL-C is said to be able to display clinical changes. In other words, it can demonstrate 
PTSD symptom severity without a diagnosis (Foa et al., 2009). 
 
Hopkins Symptom Checklist -25. The HSCL-25 is a 25-item scale, which measures 
symptoms of depression and anxiety in the previous week. It is divided into two subscales: 
Anxiety (10 items) and Depression (15 items), which together give a total score. It is scored 
on a four point rating scale, from “1” (not at all) to “4” (extremely). The score is calculated as 
the average item score, making the maximum for both subscales, as well as for the total 4. A 
minimum score is 1, and a higher score indicates more severe symptoms. A cut-off value of 
1.75 has been found to be acceptable in cross-cultural research and in refugee settings 
(Ventevogel et al., 2007). 
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Symptom Checklist, Subscale Somatization. From the SCL-90 the “Somatization” 
subscale was used. The subscale Somatization consists of 12 questions in which the 
participants are asked to rate their experiences of bodily discomfort in the previous week. The 
SCL-90 has a five point rating scale, ranging from “0” (not at all) to “4” (extremely) and the 
calculated results are interpreted as giving an estimate of current bodily discomfort, with a 
minimum score of 0 and a maximum score of 48. Cronbach’s alpha for the Swedish 
translation of the subscale is α = .80 (American version α = .86) (Fridell, Cesarec, Johansson, 
& Thorsen, 2002).  
 
WHO-5 – Wellbeing Index. In this test, five questions are asked about how the 
respondent has felt in the last two weeks (World Health Organization, 1998). The five items 
are set on a six-options scale, ranging from “0” (at no time) to “5” (all the time). The 
individual ratings are then added together, to give a potential minimum of 0 and maximum of 
25.  A score of 0 represents the worst possible “well-being”, while a score of 25 represents 
the best possible quality of life. A cutoff value of 12.5 has been considered as an indication 
for symptoms of depression, and suggests need for further examination.  
 
Pittsburgh Sleep Quality Index. The PSQI was developed for the specific use of 
measuring sleep quality in a clinical population and concerns the sleep quality within the 
previous month (Buysse, Reynolds, Monk, & Berman, 1989). It consists of seven 
components that together add to a total global score. The seven components are: subjective 
sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of 
sleep medication and daytime function. The components are scored from 0-3, and the global 
score has a possible range from 0-21, where a higher score indicates poorer sleep quality. The 
components are calculated based on answers from nineteen questions. How this is done 
differs from one component to another. Some scores correspond to a single item, whereas 
others are calculated as an equation from several items.  
  The PSQI also includes five items that can be scored by a bed partner, however these 
items do not affect the global score and were not included in this study since it could not be 
assumed that all participants had a bed partner.  
 
Symptom-Tracking. The neurofeedback program package used by the practitioners 
at the Red Cross Center included a symptom-tracking element that could help the 
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practitioners to follow the change in a subject during the course of their neurofeedback 
treatment. The full list of symptoms included in the symptom-tracking instrument showed 
more than 150 symptom fields and was regarded as too excessive for the needs of this pilot-
study.  
The idea was to have some way of observing and recording changes that might be 
taking place between the points of measurement with the other five test instruments that were 
intended for the study. The method for doing this, however, would have to be brief and 
simple so that participants would be able to complete it within a few short minutes at the 
beginning of each session. Therefore, a revised symptom-tracking instrument was designed 
for this study, in collaboration with the neurofeedback practitioners at the Red Cross Center, 
using only fifteen of the most common symptoms associated with posttraumatic stress. The 
result of this form (see Appendix 1) is scored in the form of a Visual Analog Scale, displayed 
pedagogically with colors and face symbols to help describe the extent of comfort or 
discomfort associated with the measurement options. The symptoms used were: difficulty 
falling asleep, disturbed sleep, nightmares, flashbacks, fear/worry/anxiety, rumination, 
feeling low, low self-esteem, difficulty concentrating, sensitivity to sounds, irritability, 
anger/rage, fatigue, muscle tension and headaches. Scores of the symptom areas were 
averaged together for the entire group and plotted on a graph to show the symptom 
fluctuations of the group over the course of treatment.  
 
Description of Treatment 
Neurofeedback treatment at the Red Cross Center for Victims of War and Torture, as 
explained by the two qualified practitioners, consisted of ten treatment sessions, each thirty 
minutes long. At the beginning of each session, the practitioner routinely asked the 
participant how they had felt since the previous session, both as a general question, but also 
in regards to the treatment and whether the participants had been aware of any possible 
effects. It was also of value to know whether anything in particular had happened since the 
last treatment or if the participant had specific symptoms or needs that should be addressed 
during the present session.  Then the participants would take a few minutes to fill in the 
symptom-tracking form, after which the actual treatment would begin.  
The software program CYGNET was used by the practitioners at the Red Cross 
Center, and the electrode placement points are organized according to the “International 10-
20 System of Electrode Placement” (Othmer, 2008). The type of neurofeedback training was 
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‘awake-state’ training, meaning that the subjects used visual and audio stimulus. It was also 
‘1-Channel Bipolar Training’ and the frequency used was infra-low, at 0.0-0.1 MHz. For 
more info on theory and treatment methods, see website EEG Info (n.d.), and manuals, 
Othmer (2008), Wiedermann, Sasu, & Wandernoth (2012). 
In the first few sessions of treatment, the practitioners used one of the two usual 
starting points, T4-P4 or T3-T4, for the whole thirty-minute duration. T4-P4 was the most 
commonly used starting point in this study. Then, after the patient had been through a few 
treatment sessions, the number of locations used during one session was sometimes increased 
to two, three or four different placements. The most placements that were used for one 
session during this study were four, at about 7-8 minutes each.  
During neurofeedback training, the electrodes connected to the participant’s scalp 
measured brainwave frequencies and sent that information to a computer. The participant 
could then see the activity of his brain displayed on a computer screen through a program. 
The neurofeedback practitioners at the Red Cross Center had a wide array of different 
feedback programs to choose between to display brainwave activity to the participants. The 
programs used were, for example, Advanced Media Player, Particle Editor and InnerTube, 
each having numerous different scenes and visual environments to view.  
Through the changes that occurred in the visual/audio display, the participants 
attained feedback on their brainwave activity. Since the aim of neurofeedback was to regulate 
brainwaves, desired frequencies were trained using rewards, referred to as ‘reward 
frequencies’ (for example, if clear sound is part of the rewarding feedback, a lack of desired 
frequencies might make the audio feedback sound muffled). The practitioner providing the 
feedback was able to see the brainwave fluctuations on his or her own computer screen and 
adjusted the rewards frequency to fit the subject’s needs.  
The practitioners guided the participants through each session, giving explanations 
and repeating instructions if and when necessary. The practitioners tried to be in constant 
contact with the participants during the sessions, adjusting the feedback to the participant’s 
individual needs. Sometimes this meant, for example, switching to another audio/visual 
feedback program if the participant was not comfortable with the one currently being used. 
At any point during a session, treatment could be stopped.  
Analysis of Data  
To code the data, each individual was given a random id number instead of their 
name. Each participant’s test results, along with notes recording symptoms and other relevant 
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information about what was happening in their lives from session to session, was filed by the 
practitioners and made available only to the authors of this study.  
When scoring the instruments, a missing value, such as an omitted or incomplete 
answer, was replaced by the group mean score for that particular item. This was done so that 
a missing value would not invalidate the entire instrument for that individual.  
The statistical analysis methods used were mixed-design multivariate or univariate 
analysis of variance (MANOVA/ANOVA) with the repeated measures factor ‘time’ (pre, 
post) and between-subject factor ‘group’ (treatment, control). In addition, if a significant 
interaction between/for the factors were found, t-tests were performed to further investigate. 
The results from the three individuals that initiated treatment in January were also 
evaluated and analyzed together with the data from the entire treatment group (n=12), but 
they were also examined separately as a smaller group of just those three individuals 
(referred to as “the baseline group”). No additional statistical analysis was performed on their 
results since the number of participants was too low to fulfill statistical requirements. Instead, 
their results were additionally plotted on separate graphs to view for comparison.  
A graph of the results from the session-by-session symptom-tracker measurements 
was also plotted to give a visual of what was happening with the individuals’ experience of 
their symptoms over time. 
 
Additional Ethical Considerations  
Much time was put into considering the ethics of this study, as this group is regarded 
as particularly sensitive. It was deemed by the authors and collaborators at the Red Cross 
Center that it would not be ethical to put people who have suffered severe stress and trauma 
through more stress, if avoidable. Yet at the same time, the most ethical would be to provide 
them with the best possible treatment to alleviate their symptoms, something that cannot be 
achieved without performing new treatment studies. A proposal for this study, along with an 
evaluation of ethical considerations, was submitted and approved by the University of Lund 
in Sweden.  
Some of the considerations made were that the participants should not have to endure 
psychometric testing sessions that were too long or cognitively taxing. Therefore, all of the 
tests chosen for the study, except for one, were the same tests that are regularly used in the 
Red Cross Center’s first patient assessment session. It was also considered that the patients 
would need to be well informed of the study’s purpose and given the opportunity to decline 
34 
 
participation, still allowing them other treatment options. Whoever was not placed in the 
treatment-group in for the course of this study was to be given the same opportunity for 
treatment when new openings emerged, at the end of the study when the treatment-group 
exited treatment. Participants would also be able to stop treatment at any point if they so 
desired. 
Another important consideration, bearing in mind the severity of the symptoms 
experienced by this group, was that participants would be allowed other counseling 
opportunities or medication if needed during the duration of treatment and it would not 
disqualify them from the study. 
Another viewpoint to consider when weighing ethics is to think about the treatment 
methods used at the center and see what is working and what is not. Are resources being used 
in the way that they should be? What works well and what can be improved upon to continue 
trying to improve the quality of life for these patients?  
 
Results 
 
The results are presented below, beginning with a description of the demographics of 
each group (Table 1), followed by the results of participation and attrition and a table 
showing the descriptive statistics for pre- and post-measurements (Table 2) and finally the 
results of the statistical analysis. Furthermore, a short description of the results found from 
the baseline-group and the symptom-tracking are presented, as well as additional data 
collected by the practitioners, such as documentation and observations. 
 
Demographic Comparison  
Table 1 shows the description of our treatment-group and control-group, which 
consist of, 12 and 7 males, respectively, who came to Sweden as traumatized refugees, 
sought out help at the Migration Depot, and were then remitted to the Red Cross Center for 
treatment. A majority of the participants in both groups come from Iraq, have lived in 
conditions of war and lost family and loved ones due to such conflicts. All participants are 
between 27 and 62 years old, though the treatment-group appears to be slightly older on 
average. A larger proportion of the treatment-group has served as soldiers, and a larger 
proportion of this group also lives with family members and not alone, compared to the 
control-group. In general, the members of the control-group have lived in Sweden for a 
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shorter period of time and have not been on the waiting list as long to receive treatment.  
However, when age, months on waiting list and number of years in Sweden were included in 
the statistical analysis (mixed-design MANOVA and ANOVA) as potential covariates (for 
each instrument separately), no significant results were found. 
 
Participation and Attrition 
All twelve participants in the treatment-group chose to stay in the study for the full 
course of treatment. Of those twelve, two participants, because of personal issues and the 
limitations of time for this study, were only able to complete nine sessions of neurofeedback 
before doing post-treatment measurements. Another individual was only able to complete 
eight sessions of neurofeedback before the study ended. Although it was a divergence from 
the original plan for the study, it was considered better to have the post-measurements of 
those individuals after 8-9 sessions than to exclude them from the study on account of time 
restrictions. Only seven of the nine individuals that were allotted to the control-group 
completed post-measurements. One of these individuals gained employment and no longer 
participated in activities at the Migration Depot, and the other could not make it to an 
appointment to complete post-measurements before the end of the study. None of the 
participants took part in any other type of psychological treatment during the course of the 
study, although one participant was offered an extra counseling session.   
 
  
36 
 
Table 1. 
Details about the participants 
 Treatment-Group Control-group 
Gender All male All male 
Avg. age 43.2 yrs 38.3 yrs. 
Avg. number of years in Sweden 4.6 yrs 3.7 yrs. 
Avg. months on waiting list 8.9 mos. 6.9 mos. 
Are living with spouse/children (not alone) 83% 57% 
Countries of origin Iraq: 11 (92%)  
Syria: 1 (8%) 
Iraq: 5 (71%) 
Syria: 1 (14%) 
Kuwait: 1 (14%) 
Have lived in conditions of war 92% (11/12) 100% 
Have been soldiers 67% (8/12) 29% (2/7) 
Have been imprisoned/held captive 75% (9/12) 86% (6/7) 
Have been tortured 83% (10/12) 86% (6/7) 
Have lost a loved one due to war/conflict 92% (11/12)  100% 
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Table 2. 
Descriptive Statistics for Pre- and Post-measurement   
Test   Group N Pre-measurement 
M (SD) 
Post-measurement 
M (SD) 
PCL-C: Total Treatment 12 70.14 (5.74) 63.63 (6.10) 
 Control 7 60.14 (11.26) 62.43 (11.72) 
 Intrusion Treatment 12 21.42 (2.91) 20.17 (3.30) 
  Control 7 19.29 (3.64) 20.00 (3,46) 
 Avoidance Treatment 12 27.48 (3.35) 24.13 (3.30) 
  Control 7 24.14 (5.05) 24.00 (4.43) 
 Hyperarousal Treatment 12 21.25 (2.05) 19.17 (2.48) 
  Control 7 16.71 (3.04) 18.43 (4.39) 
HSCL-25: Total Treatment 12 3.12 (.24) 2.82 (.30) 
 Control 7 2.84 (.51) 2.86 (.42) 
 Anxiety Treatment 12 3.14 (.38) 2.76 (.36) 
  Control 7 2.86 (.39) 2.91 (.40) 
 Depression Treatment 12 3.12 (.26) 2.87 (.32) 
  Control 7 2.81 (.60) 2.83 (.46) 
SCL-90:  Somatization Treatment 12 34.50 (5.79) 28.67 (5.93) 
 Control 7 27.57 (6.88) 28.29 (6.73) 
WHO-5 Total Treatment 12 3.17 (3.56)  8.08 (4.44) 
 Control 7 4.00 (3.79) 4.86 (4.34) 
PSQI 
 
Total Treatment 12 16.88 (1.97) 15.83 (2.98) 
 Control 7 16.46 (2.36) 15.93 (2.98) 
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Statistical Analysis  
 
PTSD Checklist, Civilian Version . A mixed-design MANOVA was conducted 
using the three factors: ‘time’ (pre, post), ‘group’ (treatment, control), and ‘PCL-C’. The 
levels of the factor ‘PCL-C’ correspond to the three subscales: Intrusion, Avoidance, and 
Hyperarousal. A significant main effect of ‘time’ (F(1,17) = 5.50, p = .031, η2 = .244) was 
observed, which shows that the total-group’s pre-measurement was significantly higher than 
the total-group’s post-measurement. A significant interaction between ‘time’ and ‘group’ was 
also found (F(1,17) = 22.91, p < .001, η2 = .574) which means that the difference over time 
depended on the factor ‘group’. Planned follow-up t-tests were done to elucidate the 
interaction. It was shown that the pre-measurement and the post-measurement in the 
treatment-group were significantly different (t(11) = 5.45, p < .001) revealing a significant 
reduction in scores. In the control-group no significant difference was seen from pre-
measurement and post-measurement (t(6) = -1.89, p = .108 ). Additional t-test comparing the 
groups with each other at pre-measurement showed that the treatment-group scored 
significantly higher in their mean score than the control-group (t(17) = 2.59, p = .019). 
However, a difference could not be found when conducting a t-test comparing the groups at 
post-measurement (t(17) = .30, p = .770).  
A significant main effect of ‘PCL-C’ (F(1,16) = 64.18, p < .001, η2 = .889) was 
further found, and reflected differences between the raw scores of the subscales. However, 
the factor ‘PCL-C’ did not interact with either ‘time’ or ‘group’ (maximum F = 1.52, n.s.), 
suggesting that the above-mentioned interaction between time and group was comparable for 
all three levels of the ‘PCL-C’. An illustration of the groups’ mean scores at pre- and post-
measurements can be found in figure 1a. 
 
Hopkins Symptom Checklist -25. A mixed-design MANOVA was conducted using 
the three factors: ‘time’ (pre, post), ‘group’ (treatment, control), and ‘HSCL-25’. The levels 
of the factor ‘HSCL-25’ correspond to the two subscales: Depression and Anxiety. A 
significant main effect could be seen for ‘time’ (F(1,17) = 6.66, p = .019, η2 =  .282), 
revealing that the total-group’s pre-measurement was significantly higher than the total-
group’s post-measurement. A significant interaction for ‘time’ and ‘group’ (F(1.17) = 10.48, 
p = .005, η2 = .381) was found, showing a significant difference over time that depended on 
group. A planned follow-up t-test revealed that the pre-measurement was significantly higher 
than the post-measurement for the treatment-group (t(11)= 5.08, p< .001 ), whereas for the 
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control-group it was not (t(6) = -.12 , p = .908 ). A t-test comparing the groups with each 
other at pre-measurement and post-measurement, respectively, showed that the groups were 
not significantly different at either occasion (maximum t = 1.6, n.s.).  
No significant main effect could be found for ‘HSCL-25’ (F(1,17) = .03, p = .870), 
nor could it be found to interact with any of the other factors (maximum F= 1.44, n.s.). Since 
‘HSCL-25’ was not found to interact with either ‘group’ or ‘time’, it suggests that the 
interaction between ‘time’ and ‘group’ mentioned above was comparable for all three levels 
of ‘HSCL-25’.   An illustration of the groups’ mean scores at pre- and post-measurements 
can be found in figure 1b. 
 
Symptom Checklist, Subscale Somatization. A mixed-design univariate analysis of 
variance (ANOVA) was performed, on two factors: ‘time’ (pre, post) and ‘group’ (treatment, 
control). A significant main effect of ‘time’ (F(1.17) = 11.12, p = .004, η2 = .395) could be 
seen, which shows that the total-group’s pre-measurement scores was significantly higher 
than the total-group’s post-measurement scores. A significant interaction of ‘time’ and 
‘group’ (F(1.17) = 18.19, p = .001, η2 = .517), was observed, which means that there was a 
significant difference over time that depended on the factor ‘group’. A planned follow-up t-
test showed that the pre-measurement was significantly higher than the post-measurement for 
the treatment-group (t(11) = 5.71, p < .001), whereas for the control-group it was not (t(6) = - 
.74, p = .489). A t-test comparing the groups scores with each other at pre-measurement 
revealed that the treatment-group scored significantly higher than the control-group (t(10,97) 
= 2.24, p = .047). At post-measurement, a t-test comparing the groups showed no significant 
differences (t(11.4) = .12, p = .903). An illustration of the groups’ mean scores at pre- and 
post-measurements can be found in figure 1c.  
 
WHO-5 – Wellbeing Index. A mixed-design ANOVA was performed, on two 
factors: ‘time’ (pre, post) and ‘group’ (treatment, control). A main effect of ‘time’ (F(1.17) = 
10.19, p = .005, η2 = .375) could be seen, which shows that the total-group’s pre-
measurement scores was significantly lower than the total-group’s post-measurement scores. 
An interaction of ‘time’ and ‘group’ (F(1.17 ) =  5.04, p = .038, η2 = .229), was found, 
meaning that there was once again a significant difference over time that depended on the 
factor ‘group’.  A planned follow-up t-test once again showed that the pre-measurement was 
significantly lower than the post-measurement for the treatment-group (t(11 ) = -3.73 , p = 
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.003 ), whereas for the control-group it was not  (t(6) = -1.35 , p = .225 ). Additional t-tests 
comparing the groups with each other at pre-measurement and post-measurement, 
respectively, showed no significant difference (maximum t = 1.55, n.s.). An illustration of the 
groups’ mean scores at pre- and post-measurements can be found in figure 1d. 
 
Pittsburgh Sleep Quality Index. A mixed-design ANOVA was performed, on two 
factors: ‘time’ (pre, post) and ‘group’ (treatment, control). No significant results could be 
found for the PSQI, neither main effect nor interaction (maximum F = 1.27, n.s.). No 
additional t-test was performed. An illustration of the groups’ mean scores at pre- and post-
measurements can be found in figure 1e. 
 
Baseline-group with repeated pre-treatment measurements 
Since three participants in the treatment-group were not able to start treatment until 
several weeks after their first pre-treatment measurements in October, they performed 
additional pre-treatment measurements in January, just prior to initiation of neurofeedback 
training. They were again assessed at post-treatment.  
Because of the small number of participants no t-test was performed, but a visual of 
what happened with their measurements can be seen in a plot of their mean scores (Figure 2). 
In these diagrams it is possible to see little or no improvement in the time between pre-
treatment measurements that were done in October and pre-treatment measurements that 
were done in January, while a noticeable difference can be seen between the pre-treatment 
measurements and the post-treatment measurement period. This applies to all of the tests 
except for the PSQI. 
 
Symptom Tracking Graph 
 A graph was also created to plot how the participants, on average, rated their 
symptoms on a weekly/session-to-session basis (see Figure 4). The symptom tracking 
instrument was created for the purpose of this study and is not validated. Since it had no 
corresponding control-group, no statistical analysis will be performed on the collected data.   
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Figure 1a 
 
Figure 1b 
Figure 1c 
 
 
 
 
 
Figure 1d 
 
Figure 1e 
Figure 1. Depiction of the group mean scores, pre and post-treatment. 
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Figure 2a 
 
Figure 2b 
Figure 2c 
 
 
 
Figure 2d 
 
Figure 2e 
  
Figure 2. Graphs of pre and post-treatment measurements for participants with delayed treatment 
initiation
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Additional Data 
 
Clinical Documentation. The practitioners’ meetings with their patients revealed that 
most participants had numerous stressful events happening in their lives while they were 
going through the treatment period, and sometimes these events could be seen to correspond 
with how they rated their symptoms on the symptom-tracking forms. Below are some 
examples of the kinds of outside stressors many were experiencing during the treatment 
period: 
 Several patients reported experiencing increased demands from government agencies 
- one reported that his social worker said he had to start showing improvement in his 
Swedish language course or he would be taken out of it, something he enjoyed being 
a part of. 
 Economic struggles - one individual, for example, had not received his financial 
support as expected. 
 Many had family and loved-ones who were in danger or harmed during the course of 
treatment. For example, one participant had a cousin who was killed in a raid in his 
homeland. Another participant had a nephew who was kidnapped during the weeks of 
neurofeedback treatment. 
 Fear of danger or harm for family and loved ones - one participant had a close relative 
who was forced to return to homeland. 
 
Other reported issues that could potentially have impacted treatment: 
 Relational problems - one individual was going through a separation.  
 Nightmares causing some participants to sleep less.  
 Needing medication or changes in medication dosage. 
 Having children and not being able to tolerate high levels of noise - several rated 
higher symptom levels after Christmas-break when they had to spend a lot of time at 
home with their young children. Also, children being at home sick was mentioned as 
a stressor and a cause for higher symptom ratings. 
 Alcohol use may have had an impact on treatment in the case of one participant. 
 
Clinical Observations. The neurofeedback practitioners made some personal 
observations of participants during treatments that are worth making note of. First, they noted 
that there were no drop-outs and that anytime cancelations needed to be made, participants 
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willingly rescheduled. Another observation was that some of the patients had a hard time 
staying focused and “being there” mentally for a full session of neurofeedback. They did 
however note that some of the participants who had a hard time sitting for the duration of 30-
minutes in the beginning of treatment were able to do it without a problem by their last 
treatment sessions. 
The treatment providers noticed many examples of how participants were affected by 
the neurofeedback programs. Most of these observations had to do with images that were 
shown on the computer screen and associations that the participants made with them. For 
example, one clinician was using a program with an animation of a house being built and the 
participant was sadly reminded of the house that he had lost in his homeland when he was 
forced to flee. Another participant was bothered by the image of a tunnel, which he said made 
him feel enclosed. “It feels like my life,” he said. A third example is of a participant who 
disliked a scene where the image turned dark and it looked like a storm was approaching. The 
image of a tropical beach scene reminded one participant of his first and only love and the 
life that they never got to share together because of the traumatic events that separated them. 
Many of the participants had problems with certain colors like the color “red”. “My brain 
keeps thinking that it is blood,” one participant said. Another participant was impatient and 
preferred only programs where “something happened”. Some were even upset or bothered by 
the sounds that the programs made. 
 
Discussion 
 
The people who have participated in this study have witnessed some of the most 
horrifying deeds capable of mankind. Many have been traumatized in the most malicious and 
degrading ways, resulting in physical and mental scars that will never leave them. Many have 
even been forced to take part in these same kinds of behavior or risk being further harmed 
themselves. They have veritably feared for their lives, until in some cases, even the thought 
of going on living has seemed burdening. Many have lost people who have been dear to 
them, as well as that which had given their existence coherence and meaning. They have been 
forced to leave an old life behind, under conditions that were life-threatening and terrorizing, 
and flee to a new country where they not only have to rebuild their lives, but parts of 
themselves and their own identity.  
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Documentation from neurofeedback sessions illustrate that these participants 
continued to face considerable challenges even during the time of their participation in 
neurofeedback treatment. There were constant reminders of their loss and disempowerment 
through lack of employment, insufficient housing, missing loved ones and so on. Experiences 
like these were reported by many of the participants and were the source of much reported 
worry and anxiety. Also, as illustrated by other studies and literature relating to this group, 
such threats to stability and the fulfillment of basic needs can cause tremendous stress and in 
fact be retraumatizing.  Many of the participants lived with the constant awareness that 
family members and loved ones in their homeland were still in danger, and a few participants 
actually lost people who were dear to them during the course of this study. There were even 
regular reminders of their own trauma that came in the form of nightmares and flashback.  
Even the diagnosis shared by many of them “Complex PTSD”, makes an implication 
of intricacy and difficulty. Because of the complexity of their symptoms and concurrent 
factors, such as migration related stress and the challenges involved in adapting to a new 
cultural setting, it is quite possible that it would be difficult to help them with any kind of 
treatment, irrelevant of what that treatment was.  
Because of a desire to help ease the suffering experienced by people in this situation, 
and an aspiration to contribute to the advancement of methods for effective treatment for this 
group, we set out to perform a pilot study that would examine if neurofeedback could be 
associated with a reduction in common symptoms experienced by traumatized refugees. The 
results of our study show that despite the severity and complexity of their symptoms and 
despite the difficulty in treating this group, it was possible to make a positive change in the 
symptoms of these patients.  
 
Result discussion 
 
Analysis. According to the analysis of four of the five performed test measurements, 
PCL-C, HSCL-25, SCL-90: Somatization, WHO-5, the results of the study were as 
anticipated. Neurofeedback treatment could be seen to be associated with a reduction in 
trauma-related symptoms. 
The mixed-design MANOVA for the PCL-C and HSCL-25, as well as the mixed-
design ANOVA for the SCL-90: Somatization and the WHO-5, revealed a significant main 
effect for ‘time’, showing that over time there was a reduction in raw scores considering all 
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participants. Furthermore, they showed a significant interaction for ‘time’ and ‘group’. The 
fact that ‘time’ and ‘group’ could be seen to interact significantly, means that there was a 
reduction over time that depended on the factor ‘group’. The factor ‘group’ was differentiated 
by whether the individuals were receiving neurofeedback treatment or not. Hence, the 
reduction of symptoms, seen over time, from pre-measurement to post-measurement, was 
dependent on neurofeedback treatment.  
To further investigate the significant findings, t-tests were conducted, and as 
expected, the t-tests comparing pre- and post-measurement scores for PCL-C, HSCL-25, 
SCL-90: Somatization and WHO-5 showed that a reduction in symptoms could only be seen 
in the group that had received neurofeedback treatment.  
Additional t-tests were done, comparing the two groups at the different times of 
measurements. For the PCL-C and the SCL-90: Somatization it was found that the two 
groups were significantly different from each other at pre-treatment measurements, where the 
treatment-group scored higher (meaning more symptom severity) than the control-group, but 
no such difference was observed at post-treatment.  Looking at the graphic depiction of the 
groups’ mean scores at pre- and post-measurement (Figure 1a and 1c), it is possible to see 
how the groups start out with symptom levels that are farther apart, only to converge at post-
measurement, where the symptom levels between the groups became more equal. On both of 
these instruments, the PCL-C and SCL-90: Somatization, the non-significant difference at 
post-treatment should be interpreted as an improvement for the treatment-group and suggests 
a positive result from neurofeedback treatment (since the treatment-group’s symptoms ended 
on the same level as the control-group’s were from the beginning).  
The additional t-tests for the HSCL-25 and the WHO-5, comparing the groups’ scores 
with each other at the two times of measurement, showed that the treatment-group and the 
control-group were not significantly different from each other at either pre-measurement or 
post-measurement. A look at the crossing lines on Figures 1b and 1d helps to illustrate why 
this is happening. These figures reveal different trends in the changes in scores over time for 
the two groups. The treatment-groups scores at pre-measurement reflect more severe 
symptoms initially, which then decreases over time. The control-groups’ scores on the other 
hand increased over time, and reflect more severe symptoms at post-treatment measurements. 
Again, this reveals that the treatment was associated with the desired outcome, a reduction of 
symptoms in the treatment-group.  
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Unlike the results found in the other measurements, no significant improvement could 
be seen in post-measurements from the PSQI. A closer look at Table 2 and Figure 1e, show 
that both groups have a very slight decrease in symptoms but the change is so small that it is 
not significantly different over time or between groups. Still, the treatment-groups’ symptoms 
have decreased, on average, by about one score point while the control-groups’ symptoms 
have decreased by about a half a point. It would be interesting to see if this trend would 
continue over a longer period of time, but for this study, the results were not very 
informative.  
Results from the PSQI can be interpreted to mean several things. They could mean, 
for one, that stronger results would be revealed if the treatment and comparison occurred over 
a longer period of time. On the other hand, they could also implicate that this treatment does 
not at all improve sleep quality for this group of patients, or that this test does not adequately 
measure problem areas for this particular group or the changes that might be occurring if 
treatment is making a difference.  
There seems to be an inconsistency in the fact that sleep is believed to correspond to 
many of the aspects that the other instruments measure, such as anxiety, hyperarousal, 
somatization and overall quality of life, yet the PSQI was the only instrument to show an 
insignificant value. As described earlier, the authors added this instrument because of their 
hope to measure improvement in sleep quality, but unfortunately, two of the possible 
explanations given here for the results are rather disappointing—both that neurofeedback 
treatment does not improve sleep quality or that this measurement is not a feasible one for 
this group. It seems surprising that the treatment appears to be able to significantly reduce 
many major symptoms of PTSD, but not sleep.  
  
 Baseline-group. It is also interesting to look at the data for the three individuals who 
completed two pre-treatment measurements before beginning neurofeedback training, and 
how those results compare with their post-treatment measurements.  Looking at the results 
for those tests, it is possible to see that there was no improvement, and in some cases the 
symptoms even became slightly worse between pre-treatment measurements 1 and 2. Yet 
after the conclusion of treatment, it is possible to see changes that are similar to those seen in 
the total treatment-group, with the exception of the PSQI. The graph of those three 
individuals’ results illustrates the same trend in difference, a decline in symptoms after 8-10 
sessions of treatment. Seeing that their results were about the same in pre-treatment 
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measurements 1 and 2, and then declined markedly by post-treatment measurements also 
leads to speculation that treatment could have played a part in their symptom improvement. 
 
 Covariation. An attempt was made to see if number of months on the waiting list, 
number of years in Sweden, or age of participants covaried with the results, but none of them 
were found to significantly do so. It would also have been interesting to see if length of 
trauma or number of trauma-related incidents covariated with results, but unfortunately, 
because most of the participants experienced multiple traumatic events in their lives, and the 
durations of their trauma experiences could not easily be calculated, the likelihood of 
covariation was impossible to determine.  
 
 Tolerance. It is one thing to investigate whether a treatment is beneficial for a 
particular patient group, but another aspect that is also almost equally vital is tolerability, 
whether patients are able to tolerate a treatment. Prolonged Exposure is, for example, a CBT 
method that is proven efficacious after a completed treatment, but studies show that many are 
reluctant to even start that treatment and tolerability for it appears to be low, making this 
method underutilized in clinical settings. From what can be seen in this study and under the 
conditions used in this study, tolerance for neurofeedback training seems high, since none of 
the individuals in the treatment-group dropped out. This may also have been in part because 
the conditions of this study allowed flexibility and the neurofeedback providers tried to 
personalize the treatment sessions as much as possible and make it convenient to them in 
whatever ways they could. It is feasible to assume that more restrictive method could 
possibly have resulted in more drop-outs from the treatment-group. 
On the other hand, in the future, it appears more thought should be put into what 
neurofeedback programs are used for this patient group, since many of the participants found 
themselves affected by the images they saw and the associations they made to those images, 
even though it is hard to know what memories an image might trigger. Though it was not so 
for this study, the programs could be a factor that could potentially cause intolerability for 
some patients. 
 
Symptom tracking. As this was a pilot study, it seemed important to try to extract as 
much information from it as possible as a basis for further studies. Since this study is the first 
to examine the use of neurofeedback in this population, there might have been answers 
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waiting to be found to questions we didn’t know to ask. One opportunity the researchers saw 
in adding the symptom tracking instrument was the possibility of different symptoms being 
associated with neurofeedback in different ways. For example, if one symptom changed only 
during the first five sessions, but not the last five. Had this happened, it would have been 
possible to see in the graphic depiction. No attempts were made to draw any conclusions 
from the symptom tracking information on a group level. This was partly because of 
limitations in time and the vast material collected by the symptom tracking instrument, but 
also the lack of a comparison group. It is possible that more interesting information could 
have been found, had the material been investigated more thoroughly.  On an individual 
level, it was possible at times to see a relationship between how they rated themselves on 
certain symptoms and how those ratings sometimes corresponded with particular events 
occurring in their personal lives, as recorded by the clinical observations.  
 
Improvement. What do improved scores on the PCL-C, HSCL-25, SCL-90: 
Somatization, WHO-5 and PSQI actually mean for the participants in the treatment group? 
What do they say about their symptoms? As explained in the previous section on 
“Instruments”, the PCL-C is able to measure symptoms of PTSD for civilians, organized 
under the symptom clusters ‘Intrusions’, ‘Avoidance’ and ‘Hyperarousal’. The absence of an 
interaction for the factor ‘PCL-C’ suggests that there is no difference between how theses 
symptom clusters are affected by this treatment. It appears to affect them all in the same way. 
The results show that the difference on the PCL-C was significantly lower at the post-
measurement than at the pre-measurement. When looking at the descriptive statistics for the 
subscales (Table 2), the actual change in mean scores for the treatment-group appears to be 
small. On ‘Intrusion’ the mean score goes from 21.42 to an average of 20.17 (where the 
maximum is 25), on ‘Hyperarousal’ the decrease was from 21.3 to19.2 (maximum = 25), and 
on ‘Avoidance’ it went from 27.5 to 24.1, (maximum = 35). This indicates that even though 
the difference from the beginning of the treatment to the end of treatment is significant for 
the total scale, the post-measurements reflect a group of individuals that still score high on all 
three clusters of PTSD symptoms and are in need of more treatment.  
The Hopkins Symptom Checklist -25 (HSCL-25) showed a significant improvement 
for the treatment group after treatment. When looking at the scores for the subscales 
individually however, the results for both times of measurement the mean score for the 
treatment-group are still above the 1.75 cut-off value, which is interpreted as a need for 
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further attention. On the subscale Anxiety, the mean score decreased from 3.14 to 2.76 (with 
a maximum of 4 points), on the subscale Depression a decrease from 3.17 to 2.86 (maximum 
= 4) could be observed, which means a slight reduction in symptoms of anxiety and 
depression for these individuals as a group. As with the PCL-C, the absence of an interaction 
for the factor ‘HSCL-25’ suggests that there is no difference between how the symptoms 
measured by these subscales are affected by this treatment, meaning the treatment appears 
affect them both in the same way. 
On the somatization scale (SCL-90), which measures how individuals experience and 
communicate psychological distress in bodily symptoms, treatment-group participants’ scores 
dropped, a significant finding, from a mean of 34.5 to 28.7 at post-treatment, implying that 
their bodily discomfort is at least somewhat lessened.  
Measurements on the WHO-5 scale, which indicate a person’s experience of ‘well-
being’ and ‘quality of life’, show a positive increase from 3.17 to 8.08 on a 25-point scale.  
This entails that both pre- and post-measurement showed a mean score below the cut-off 
value of 12.5, suggesting a need for further investigation into possible symptoms of 
depression. This was also the case for the control-group where both measurements (4.00 and 
4.86 for pre and post-measurement) fell below the cutoff.  
When considering the level of symptoms that the scores reflect, and also specific cut-
off values that are used in clinical assessment of patient symptoms, it is apparent that the 
post-measurement results continue to reflect a group that is experiencing severe symptom 
levels.  A neurofeedback treatment of ten sessions might be associated with a significant 
reduction of symptoms, but ten sessions does not appear to be enough to bring the symptoms 
to an acceptable, “healthy” level. These patients still need to be considered for care and 
treatment, neurofeedback or otherwise. 
 
Limitation to Study 
 
Method. The main limitation to this study is that, since no randomization occurred, 
no firm conclusions can be made concerning causality and what actually caused the observed 
improvements.  
This study has a quasi-experimental design, with a non-equivalent control-group. If 
no control-group had been included, this study could have done little more than describe a 
change occurring over time, with little information as to what was facilitating that change. A 
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non-treatment control-group was included in this study in order to provide an opportunity to 
compare and “control” for the main factor that was assumed to be associated with the 
possible change (neurofeedback treatment), even if nothing conclusive could be said. The 
ideal would have been for this non-treatment control-group to be as similar to the treatment-
group as possible. 
All of the participants were therefore chosen from the Migration Depot, in an attempt 
to account for some potential confounding factors. Most individuals at the center came from 
the same native countries, had come to Sweden within recent years, and were assumed to 
have the same external support. So when splitting them into two groups, the only aspect that 
was taken into consideration was the amount of time the individuals had been on the waiting 
list (exceptions to this were the three individuals who were offered placement in the 
treatment-group but declined and then consented to participation in the control-group). It was 
understood that this could potentially make the groups uneven, but otherwise, it was hoped 
that the groups would be comparable. When looking at Table 1, it can be observed that they 
were in many ways.  
Still, the initial measurements revealed that the groups were in fact unequal, since the 
treatment-group had symptoms that were more severe than the non-equivalent control group 
(significantly on the PCL-C and SCL-90: Somatization). Because the groups were not 
randomized, this initial difference cannot be assumed to be caused by chance, but might be a 
reflection of more systematic factor which might be associated with, or even causing, the 
improvement in the treatment group and/or the lack of improvement in the control-group. 
 
Confounding factors. In this study, it was difficult to control for all potential factors 
that could have an influence on the participants. Several factors were identified as potential 
confounders and any of them may have had an impact on the observed improvement in the 
treatment-group.  
To begin with, a few participants were on medication and one participant was offered 
a counseling session. It was deemed unethical if they were denied such possibilities and these 
were not included as exclusion criteria for the study. With such a small number of 
participants, removing individuals with such needs from the study’s results would have been 
unfortunate, and it was assumed that this study may not even have been feasible if these 
possibilities were not allowed. 
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Outside factors, outside the control of this study, could have had an impact on the 
symptoms experienced by the participants. For example, if a participant were informed that 
they were granted or denied citizenship, if relatives or loved ones were endangered or 
harmed, if they gained employment, went through a divorce/separation or were dealing with 
other issues in their private lives. 
Differences in the two providers of the neurofeedback treatment may also have been 
able to impact outcomes. For example, what visual programs the providers tended to choose 
or find most useful, or what exact locations they selected for placement of electrodes. The 
two providers differed in gender and had separate educational and professional backgrounds. 
The contacts the participants made with these two treatment providers could have differed 
depending on a number of varying aspects including the roles they had at RKC. For example, 
the neurofeedback treatment provider who was also the center’s only physician said that it 
was not uncommon for the participants to ask about medicine or prescription renewals when 
they met with her, while the provider who otherwise worked as a physical therapist at the 
center often got into discussions with participants about other somatic problems. 
“Alliance”, another factor relating to the treatment providers, may have had an effect. 
“Alliance” is the connection or relationship made between the patient and the treatment 
provider, and has been said to be the most important condition influencing treatment 
outcomes (Safran & Muran, 2000). In discussions with the neurofeedback providers during 
the course of the study, they remarked that patients seemed to have “great confidence” in 
them as people who could help them. They also believed that it meant a lot to the patients just 
having someone to go to who heard their problems and tried to help them—that the contact in 
itself was meaningful and gave them hope. They believed that the way they treated and 
attended to their patients with respect and consideration for their needs, even when not 
related directly to neurofeedback treatment, was also an essential part of treatment.  
Factors about the treatment itself, aside from the actual “feedback,” can have a type 
of effect on the participants. For example, participating in the neurofeedback treatment could 
be a way of getting any kind of contact or help, or perhaps just being at the treatment center 
itself and having basic needs met might have given the participants some sense of comfort. 
Another example is that the treatment and the feedback process might have had a way of 
increasing the participants’ understanding of the troubles that they had been experiencing 
which might have had a positive or perhaps calming effect. For, example the feedback might 
have made their symptoms more concrete for them, validating them and their experiences. 
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Finally, it is even possible that the control-group consciously or subconsciously 
wanted to rate the same level of symptoms at post-measurement as they did at pre-
measurement. Likewise, the treatment-group could have subconsciously or consciously 
wanted to rate an improvement in their symptoms. 
 
Instruments. The instruments used to measure the participant’s symptoms are also an 
area where limitations for this study can be discussed. The choice to use the PCL-C, HSCL-
25 and SCL-90 (Somatization) and the WHO-5 was partly out of convenience because they 
are already a part of the standard introduction procedure for patients at the Red Cross Center, 
and because use of these same tests would hopefully ease the implementation of methods for 
continued documentation and research at the center. However these tests were also chosen 
because of their wide use and knowledge that they are good for reliable measures. 
The PSQI was chosen, on the other hand, because the authors of this study were 
looking for a reliable measurement to see if or how much sleep could be improved by using 
neurofeedback in this group, and this is the test that was most recommended. It was also 
important that the method of measuring sleep not be too intrusive or complicated or outside 
the means that were available in performing this study. For example, there was no possibility 
of using a sleep laboratory where sleep could be measured objectively, so for this study, a 
self-report questionnaire would have to suffice. From the experience gained by using the 
PSQI for this study however, we, the authors, have found that it has not fully been to our 
satisfaction.  
The PSQI gives a total score, which is the added value of seven components. These 
component scores are attained by filling in different equations using the data given in the 
different question answers. The main hindrance was that there were a lot of blanks or 
incomplete answers given by the participants when they filled in the PSQI, resulting in an 
omitted component score, and thus an omitted total score. Though an Arabic translation was 
used, many participants seem to misunderstand one or more of the question.  
For component number four, ”habitual sleep efficiency”, data from three different 
questions have to be figured together, using the answers from questions number one, three 
and four. The questions are formulated “How many hours do you usually sleep” (question 4), 
“What time do you usually go to bed” (question 1) and “What time do you usually wake up” 
(question 3). To calculate the component score, you first have to calculate the number of 
hours spent in bed (from the answer on question 1 and question 3), then divide the answer on 
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question 4 with that number. This gives a percentage value of how many of the hours spent in 
bed were spent asleep, which is rated on a scale from 0-3 (where higher is worse). A missing 
or difficult-to-interpret answer on any of these questions means that the components score 
cannot be calculated.  
For most of the PSQIs filled out by participants in this study, giving answers to these 
three specific questions did not seem to be as simple as the makers of the test seemed to have 
expected. Sometimes the participants were not satisfied to give one numeric answer and 
instead chose to write comments in the margins, saying things like “it varies” (for all three of 
those questions), or “several times” (for “what time do you wake up”) and so on. Question 
number four was especially important, because it is necessary for the computation of two 
different component score fields (component scores three and four). Omission on question 
four meant an omission on two different component scores. In total, six missing values were 
recorded for the PSQI, four in the treatment-group (question 2, 3 and 4, where 4 occurred 
twice) and two in the control-group (question 1 and 4). 
Another critic is that these questions do not appear to appropriately reflect the broken 
sleep pattern of many of these participants, where they fall asleep, wake up, fall asleep and 
wake up several times. A person who sleeps for only two or three hours can get a low score 
(meaning that effective sleeping is not such a problem for them) as long as they are sleeping 
for the hours that they are in bed. For example, a person who says that they go to bed at 
11:00pm and then gets up at 2:00am is only in bed for three hours. If that person also 
answered the question “how many hours do you sleep” with three hours, then the equation for 
judging their sleep effectiveness says that they are at 100% and is scored at the minimum, “0” 
for that component score. It seems quite obvious that a person sleeping only 3 hours a night 
on a regular basis is having trouble sleeping, and whether that person lays in bed awake or 
gets out of bed and does something else in that time does not diminish or change the fact that 
the person is having a problem. However, the person who chooses to lie in bed and toss and 
turn a few hours while they are not sleeping would receive a higher (more negative) score on 
that component area. 
In addition, scoring for component-score number five requires adding the sums of 
questions 5a to 5j, where parts 5a-5i represent problems that have interrupted the individual’s 
sleep, problems such as headaches or nightmares. Question “5j” however, represents “other”, 
and allows the respondent to fill in their own answer example of something that usually 
disturbs their sleep. Not having an extra item to name means that the field is scored as a “0”, 
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which can substantially reduce the score for the entire component, something the authors of 
this study find a bit questionable.  
One final note about the PSQI is that the scoring for this test, more so than for any of 
the other instruments used in this study, is very dependent us, the authors. The other tests 
were scored simply by adding together the total number values of the answers marked. In this 
test, participants were required to provide information of their own in the answer fields, and 
that information often needed interpretation. We, and the interpretations of the answers that 
we had to make, could have affected the efficacy of the instrument!  
 
 Gender. All of the participants in the sample are men and it is widely known that 
symptoms of PTSD are twice as common among women. Though there is no way of knowing 
whether females would respond to neurofeedback treatment in the same way, previous 
studies in PTSD treatments have not been able to link outcomes to gender. Still, effects that 
can depend on gender would also be an interesting area to investigate, and a sample that 
included both male and female participants may have made it more possible to draw further 
conclusions and generalizations from the study. 
  
Stabilization. According to the neurofeedback treatment providers, it would have 
been better if the participants had already achieved a higher level of stabilization before 
beginning the treatment. A certain basic level of outside care and stabilization was expected 
when deciding to take a sample from the Migration Depot, but unfortunately, due to a recent 
restructuring of that center and new demands that were to be made on the patients getting 
services from that center, this was not the case. Instead, during the first few sessions of 
neurofeedback, participant were coming to the treatment providers with papers from the 
Employment Agency and Immigration Office and question and concerns about things 
completely unrelated to treatment. At that point, it was difficult to see them as being able to 
be receptive to treatment.  
 
Findings in Relation to Other Research 
The findings from this study are in concurrence with the limited research done within 
adjacent areas. Previously two studies have examined the effect of EMG biofeedback with 
veterans and traumatized refugees. Both studies were able to link EMG biofeedback with a 
decrease in symptoms related to PTSD. Muller (2009) found a significant improvement for 
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PTSD symptoms, anxiety and depression. Peniston (1986, referred in Graap & Freides, 
1998), found that EMG biofeedback led to a decrease in muscle tension, nightmares and 
flashbacks. In this present study, these same symptoms are measured (by the PCL-C, HSCL-
25, SCL-90: Somatization) and here a significant reduction was shown in association with 
neurofeedback. Even though the method of biofeedback was different, all studies support the 
use of biofeedback in the treatment of PTSD and traumatization. 
The result in this study is also in concurrence with the previous research performed 
using neurofeedback for PTSD related symptoms. Peniston and Kulkosky (1991, referred in 
Graap & Freides, 1998), showed that a combination of alpha/theta neurofeedback and 
temperature biofeedback, led to a decrease in nightmares and a significant reduction in the 
MMPI subscales: depression and PTSD. Previous non-controlled pilot-studies have also been 
able to link infra-low (the protocol used in this study) neurofeedback with a decrease in 
PTSD related symptoms using a sample consisting of veterans. Othmer (2012) reported that 
75 % of his sample experienced a decrease in PTSD related symptom after less than 10 
sessions of infra-low neurofeedback.  
Niv (2013) reported that pilot-studies conducted by the U.S. Navy, using a 
conjunction of alpha/theta and infra-low training, over a treatment course of 20 sessions, 
showed promising results. Niv reports that 45 symptoms were tracked, many linked to PTSD 
and traumatization, but only gives examples of observed effect-sizes for depression (.84), 
sleep-related symptoms (.8) and migranines (.5). This reported effect seen for sleep-related 
symptoms is the only previous finding that is not in concurrence with this study, where no 
change could be seen in sleep quality.  If this is due to the chosen instrument, the 
combination of infra-low with alpha/theta or the number of sessions, one can only speculate.  
All studies, with the exception of Muller, have used a sample consisting of veterans. 
In this present study, 67 % of the sample had been soldiers, making them also veterans. The 
difference is that instead of returning home, these individuals have been forced to flee to a 
new county, which in itself can bring about extraordinary challenges and cause severe stress.   
 
Suggestions for Future Research 
Again, the purpose of this pilot study was to see whether neurofeedback could be 
associated with a reduction in symptoms experienced by refugees who have been victims to 
the traumas of war and torture. The results of this study show that the treatment can be 
associated with symptom improvements and the findings are comparable with other studies 
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on the effects of biofeedback and neurofeedback on symptoms of PTSD. Another purpose of 
this study was to find out how to plan for future opportunities to research and build 
knowledge about how best to treat this challenging group, and in this area, it has given much 
insight.  
To begin with, in future studies on neurofeedback treatment for traumatized refugees, 
it would be better to be sure that the group has sufficient help and support outside of the 
study to make sure that they are adequately stabilized and receptive to treatment.  One 
suggestion is to begin with the study in another form of treatment such as group therapy, and 
where they would be assured to have contact with someone who could assist them with other 
issues and concerns. 
Other testing methods would also be useful, such as a better way to measure sleep 
that is more objective, if ethically possible. Also, in a future study, it would be interesting to 
investigate other problem areas for people suffering symptoms of PTSD. This could include 
using other tests to measure areas such as concentration and/or emotional regulation. A 
continual performance test (CPT) would, for example, be a suitable form of objective 
measurement.  
In the future, of course, it would be desirable to do a study on a larger scale with more 
participants, or where measurements could also be made over a longer period of time. The 
significant results of this study, further justify the formation of a more standardized, 
randomized study that would be able to attest for causality. One possible way for designing a 
randomized study with an equivalent control-group, that would be ethical at the same time, 
would be to compare two groups where one is provided with one form of treatment, such as 
cognitive behavioral therapy or group therapy, while the other group has that same form of 
therapy and, in addition, neurofeedback treatment.  A randomized waiting-list design would 
be another suitable and ethical alternative. 
The results from the small baseline-group indicate that the inclusion of a baseline 
might further benefit a study designed to investigate causality, since the graphic depiction in 
this study indicate no difference between the two pre-measurements, whereas both pre-
measurements appear to be different from the post-measurement. A time series design might 
also be an option worth considering for a future study. 
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Conclusion 
 
This pilot-study is quite possibly the first of its kind to consider the use of 
neurofeedback treatment as a method for treating patients who have not only been victims of 
war and trauma, but who are also faced with the added stressors of life as refugees. The aim 
of this study was to see if neurofeedback treatment could be found to be associated with a 
significant reduction of the common symptoms suffered by this particular patient group. An 
additional goal was to gain useful information for future studies on how to better treatment 
methods for this group. The results revealed a significant improvement in the treatment-group 
at the completion of treatment. This improvement was evident by the reduction found in 
symptoms of PTSD, anxiety, depression and somatization, and the increase in quality of life. 
Therefore, neurofeedback treatment has been shown to be associated with a reduction in 
PTSD-related symptoms for traumatized refugees. It is noteworthy, however, to state that this 
reduction was not enough to bring the participants to a “healthy” symptom level, indicating 
that more than 10-sessions should be considered and these patients still need to be provided 
with continued care and treatment options. Additionally, findings from this study also show 
that neurofeedback treatment can be tolerable for this patient group and that an ethically 
designed RCT study would be well motivated.  
 
Afterword 
 
 Just after the completion of all of the treatments to be included in this study, one of the 
treatment practitioners happened upon one of the participants who had been a part of the 
treatment-group. The participant told him that for several years, he had constantly 
experienced a feeling of pressure in his chest. Yet at the end of treatment, that feeling which 
had caused so much discomfort and restriction in his daily life was suddenly relieved. Now 
when he woke up, he took a shower and shaved, activities that he had seldom had the desire 
or energy to make a regular routine in the past few years. For a long time, he had generally 
preferred to stay inside, but he now enjoyed going outside and walking to the park, where he 
watched children playing, reminding him of his grandchildren. For him, the difference 
brought about by the treatment experience had improved his daily life in a drastic way. 
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Appendix 1 
Neurofeedback – Symptom Tracking 
Hur har du upplevt följande besvär under den senaste veckan? 
 Svara med en siffra enligt nedanstående skala. 
      Inget besvär    Lätt besvärande   Måttligt besvärande    Medelsvårt besvärande     Svårt besvärande     Outhärdligt    Värsta tänkbara besvär 
 
 
 
 
Patient-id: 
   
NFB-
session: 
   
Behandlare: 
   
Datum: 
   
Svårighet att somna   
    
Täta uppvaknande   
    
Mardrömmar   
    
Påträngande minnesbilder   
    
Rädsla/oro/ångest   
    
Grubblande   
    
Nedstämdhet   
    
Bristande självkänsla   
    
Bristande koncentration   
    
Ljudkänslighet   
    
Irritabilitet   
    
Ilska/utbrott   
    
Trötthet/utmattning   
    
Muskelspänningar   
    
Huvudvärk   
    
